JPH0484134A - Silver halide photographic sensitive material - Google Patents
Silver halide photographic sensitive materialInfo
- Publication number
- JPH0484134A JPH0484134A JP20080990A JP20080990A JPH0484134A JP H0484134 A JPH0484134 A JP H0484134A JP 20080990 A JP20080990 A JP 20080990A JP 20080990 A JP20080990 A JP 20080990A JP H0484134 A JPH0484134 A JP H0484134A
- Authority
- JP
- Japan
- Prior art keywords
- group
- silver halide
- general formula
- hydrogen atom
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- -1 Silver halide Chemical class 0.000 title claims abstract description 108
- 229910052709 silver Inorganic materials 0.000 title claims abstract description 69
- 239000004332 silver Substances 0.000 title claims abstract description 69
- 239000000463 material Substances 0.000 title claims abstract description 30
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 52
- 125000003118 aryl group Chemical group 0.000 claims abstract description 38
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 27
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims description 38
- 125000000623 heterocyclic group Chemical group 0.000 claims description 38
- 239000000839 emulsion Substances 0.000 claims description 33
- 125000003342 alkenyl group Chemical group 0.000 claims description 27
- 125000000304 alkynyl group Chemical group 0.000 claims description 26
- 125000001424 substituent group Chemical group 0.000 claims description 21
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims description 6
- 238000009792 diffusion process Methods 0.000 claims description 5
- 125000004104 aryloxy group Chemical group 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 239000000126 substance Substances 0.000 claims description 4
- 125000003302 alkenyloxy group Chemical group 0.000 claims description 3
- 125000004433 nitrogen atom Chemical group N* 0.000 claims description 3
- 238000001179 sorption measurement Methods 0.000 claims description 3
- 229940126062 Compound A Drugs 0.000 claims 1
- NLDMNSXOCDLTTB-UHFFFAOYSA-N Heterophylliin A Natural products O1C2COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC2C(OC(=O)C=2C=C(O)C(O)=C(O)C=2)C(O)C1OC(=O)C1=CC(O)=C(O)C(O)=C1 NLDMNSXOCDLTTB-UHFFFAOYSA-N 0.000 claims 1
- 125000005133 alkynyloxy group Chemical group 0.000 claims 1
- 125000001820 oxy group Chemical group [*:1]O[*:2] 0.000 claims 1
- 230000006911 nucleation Effects 0.000 abstract description 6
- 238000010899 nucleation Methods 0.000 abstract description 6
- 238000012545 processing Methods 0.000 abstract description 5
- 229910052740 iodine Inorganic materials 0.000 abstract description 4
- 150000001412 amines Chemical class 0.000 abstract description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 39
- 125000000325 methylidene group Chemical group [H]C([H])=* 0.000 description 32
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 20
- 238000000034 method Methods 0.000 description 14
- 239000000203 mixture Substances 0.000 description 13
- 108010010803 Gelatin Proteins 0.000 description 12
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 12
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 12
- 239000008273 gelatin Substances 0.000 description 12
- 229920000159 gelatin Polymers 0.000 description 12
- 235000019322 gelatine Nutrition 0.000 description 12
- 235000011852 gelatine desserts Nutrition 0.000 description 12
- 239000002245 particle Substances 0.000 description 11
- 238000011161 development Methods 0.000 description 9
- 229910052739 hydrogen Inorganic materials 0.000 description 9
- 239000000084 colloidal system Substances 0.000 description 8
- 239000004094 surface-active agent Substances 0.000 description 8
- 239000011241 protective layer Substances 0.000 description 7
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 6
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 6
- 125000004005 formimidoyl group Chemical group [H]\N=C(/[H])* 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- 125000005647 linker group Chemical group 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 4
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 4
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 4
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 4
- LEQAOMBKQFMDFZ-UHFFFAOYSA-N glyoxal Chemical compound O=CC=O LEQAOMBKQFMDFZ-UHFFFAOYSA-N 0.000 description 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 4
- 239000004848 polyfunctional curative Substances 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 4
- SBYHFKPVCBCYGV-UHFFFAOYSA-N quinuclidine Chemical group C1CC2CCN1CC2 SBYHFKPVCBCYGV-UHFFFAOYSA-N 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- 230000035945 sensitivity Effects 0.000 description 4
- ZUNKMNLKJXRCDM-UHFFFAOYSA-N silver bromoiodide Chemical compound [Ag].IBr ZUNKMNLKJXRCDM-UHFFFAOYSA-N 0.000 description 4
- 239000011734 sodium Substances 0.000 description 4
- 125000000472 sulfonyl group Chemical group *S(*)(=O)=O 0.000 description 4
- MAUMSNABMVEOGP-UHFFFAOYSA-N (methyl-$l^{2}-azanyl)methane Chemical compound C[N]C MAUMSNABMVEOGP-UHFFFAOYSA-N 0.000 description 3
- JKFYKCYQEWQPTM-UHFFFAOYSA-N 2-azaniumyl-2-(4-fluorophenyl)acetate Chemical compound OC(=O)C(N)C1=CC=C(F)C=C1 JKFYKCYQEWQPTM-UHFFFAOYSA-N 0.000 description 3
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical compound C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 description 3
- 229910021612 Silver iodide Inorganic materials 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000002252 acyl group Chemical group 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- 150000002429 hydrazines Chemical class 0.000 description 3
- 125000001624 naphthyl group Chemical group 0.000 description 3
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 3
- 125000003386 piperidinyl group Chemical group 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 3
- 229930182490 saponin Natural products 0.000 description 3
- 150000007949 saponins Chemical class 0.000 description 3
- 235000017709 saponins Nutrition 0.000 description 3
- 230000001235 sensitizing effect Effects 0.000 description 3
- 229940045105 silver iodide Drugs 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 235000010265 sodium sulphite Nutrition 0.000 description 3
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea group Chemical group NC(=S)N UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 3
- YXIWHUQXZSMYRE-UHFFFAOYSA-N 1,3-benzothiazole-2-thiol Chemical compound C1=CC=C2SC(S)=NC2=C1 YXIWHUQXZSMYRE-UHFFFAOYSA-N 0.000 description 2
- PLIKAWJENQZMHA-UHFFFAOYSA-N 4-aminophenol Chemical compound NC1=CC=C(O)C=C1 PLIKAWJENQZMHA-UHFFFAOYSA-N 0.000 description 2
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 2
- 229930024421 Adenine Natural products 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical group C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 229960000643 adenine Drugs 0.000 description 2
- 239000003513 alkali Substances 0.000 description 2
- 125000002947 alkylene group Chemical group 0.000 description 2
- 125000004397 aminosulfonyl group Chemical group NS(=O)(=O)* 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 125000004369 butenyl group Chemical group C(=CCC)* 0.000 description 2
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000000480 butynyl group Chemical group [*]C#CC([H])([H])C([H])([H])[H] 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- YCIMNLLNPGFGHC-UHFFFAOYSA-N catechol Chemical compound OC1=CC=CC=C1O YCIMNLLNPGFGHC-UHFFFAOYSA-N 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 239000002872 contrast media Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 125000000816 ethylene group Chemical group [H]C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 229940015043 glyoxal Drugs 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 125000005843 halogen group Chemical group 0.000 description 2
- 230000002209 hydrophobic effect Effects 0.000 description 2
- 230000001771 impaired effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 239000006224 matting agent Substances 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 229910021645 metal ion Inorganic materials 0.000 description 2
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 239000003755 preservative agent Substances 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- 125000005147 toluenesulfonyl group Chemical group C=1(C(=CC=CC1)S(=O)(=O)*)C 0.000 description 2
- RVXJIYJPQXRIEM-UHFFFAOYSA-N 1-$l^{1}-selanyl-n,n-dimethylmethanimidamide Chemical compound CN(C)C([Se])=N RVXJIYJPQXRIEM-UHFFFAOYSA-N 0.000 description 1
- GGZHVNZHFYCSEV-UHFFFAOYSA-N 1-Phenyl-5-mercaptotetrazole Chemical compound SC1=NN=NN1C1=CC=CC=C1 GGZHVNZHFYCSEV-UHFFFAOYSA-N 0.000 description 1
- VILCJCGEZXAXTO-UHFFFAOYSA-N 2,2,2-tetramine Chemical compound NCCNCCNCCN VILCJCGEZXAXTO-UHFFFAOYSA-N 0.000 description 1
- BDKLKNJTMLIAFE-UHFFFAOYSA-N 2-(3-fluorophenyl)-1,3-oxazole-4-carbaldehyde Chemical compound FC1=CC=CC(C=2OC=C(C=O)N=2)=C1 BDKLKNJTMLIAFE-UHFFFAOYSA-N 0.000 description 1
- GVNVAWHJIKLAGL-UHFFFAOYSA-N 2-(cyclohexen-1-yl)cyclohexan-1-one Chemical compound O=C1CCCCC1C1=CCCCC1 GVNVAWHJIKLAGL-UHFFFAOYSA-N 0.000 description 1
- QPKNFEVLZVJGBM-UHFFFAOYSA-N 2-aminonaphthalen-1-ol Chemical compound C1=CC=CC2=C(O)C(N)=CC=C21 QPKNFEVLZVJGBM-UHFFFAOYSA-N 0.000 description 1
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 description 1
- VDHIEQOYPSVNIM-UHFFFAOYSA-N 2-hexyldecyl 2-ethylhexanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)C(CC)CCCC VDHIEQOYPSVNIM-UHFFFAOYSA-N 0.000 description 1
- AYHBRSKXFVQPPX-UHFFFAOYSA-M 2-methyl-1-(2-phenylethyl)pyridin-1-ium;bromide Chemical compound [Br-].CC1=CC=CC=[N+]1CCC1=CC=CC=C1 AYHBRSKXFVQPPX-UHFFFAOYSA-M 0.000 description 1
- LDZYRENCLPUXAX-UHFFFAOYSA-N 2-methyl-1h-benzimidazole Chemical compound C1=CC=C2NC(C)=NC2=C1 LDZYRENCLPUXAX-UHFFFAOYSA-N 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- XSFKCGABINPZRK-UHFFFAOYSA-N 4-aminopyrazol-3-one Chemical compound NC1=CN=NC1=O XSFKCGABINPZRK-UHFFFAOYSA-N 0.000 description 1
- ZFIQGRISGKSVAG-UHFFFAOYSA-N 4-methylaminophenol Chemical compound CNC1=CC=C(O)C=C1 ZFIQGRISGKSVAG-UHFFFAOYSA-N 0.000 description 1
- LRUDIIUSNGCQKF-UHFFFAOYSA-N 5-methyl-1H-benzotriazole Chemical compound C1=C(C)C=CC2=NNN=C21 LRUDIIUSNGCQKF-UHFFFAOYSA-N 0.000 description 1
- WSGURAYTCUVDQL-UHFFFAOYSA-N 5-nitro-1h-indazole Chemical compound [O-][N+](=O)C1=CC=C2NN=CC2=C1 WSGURAYTCUVDQL-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- DHXGNDYOCQCVEF-UHFFFAOYSA-N CC1=CC2=C(NN=N2)C=C1.BrC1=CC2=C(NN=N2)C=C1 Chemical compound CC1=CC2=C(NN=N2)C=C1.BrC1=CC2=C(NN=N2)C=C1 DHXGNDYOCQCVEF-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 101150065749 Churc1 gene Proteins 0.000 description 1
- DFQVGTFDFGVTGK-KVVVOXFISA-M ClC(C(=O)[O-])CCCCCC\C=C/CCCCCCCC.[K+] Chemical compound ClC(C(=O)[O-])CCCCCC\C=C/CCCCCCCC.[K+] DFQVGTFDFGVTGK-KVVVOXFISA-M 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- SXRSQZLOMIGNAQ-UHFFFAOYSA-N Glutaraldehyde Chemical compound O=CCCCC=O SXRSQZLOMIGNAQ-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910002651 NO3 Inorganic materials 0.000 description 1
- 239000000020 Nitrocellulose Substances 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 102100038239 Protein Churchill Human genes 0.000 description 1
- 101000650578 Salmonella phage P22 Regulatory protein C3 Proteins 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229910021607 Silver chloride Inorganic materials 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-N Sulfurous acid Chemical class OS(O)=O LSNNMFCWUKXFEE-UHFFFAOYSA-N 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 101001040920 Triticum aestivum Alpha-amylase inhibitor 0.28 Proteins 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Natural products NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- FJWGYAHXMCUOOM-QHOUIDNNSA-N [(2s,3r,4s,5r,6r)-2-[(2r,3r,4s,5r,6s)-4,5-dinitrooxy-2-(nitrooxymethyl)-6-[(2r,3r,4s,5r,6s)-4,5,6-trinitrooxy-2-(nitrooxymethyl)oxan-3-yl]oxyoxan-3-yl]oxy-3,5-dinitrooxy-6-(nitrooxymethyl)oxan-4-yl] nitrate Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O)O[C@H]1[C@@H]([C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@@H](CO[N+]([O-])=O)O1)O[N+]([O-])=O)CO[N+](=O)[O-])[C@@H]1[C@@H](CO[N+]([O-])=O)O[C@@H](O[N+]([O-])=O)[C@H](O[N+]([O-])=O)[C@H]1O[N+]([O-])=O FJWGYAHXMCUOOM-QHOUIDNNSA-N 0.000 description 1
- SJOOOZPMQAWAOP-UHFFFAOYSA-N [Ag].BrCl Chemical compound [Ag].BrCl SJOOOZPMQAWAOP-UHFFFAOYSA-N 0.000 description 1
- XCFIVNQHHFZRNR-UHFFFAOYSA-N [Ag].Cl[IH]Br Chemical group [Ag].Cl[IH]Br XCFIVNQHHFZRNR-UHFFFAOYSA-N 0.000 description 1
- TUCNEACPLKLKNU-UHFFFAOYSA-N acetyl Chemical compound C[C]=O TUCNEACPLKLKNU-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000004442 acylamino group Chemical group 0.000 description 1
- 125000004423 acyloxy group Chemical group 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 125000003282 alkyl amino group Chemical group 0.000 description 1
- 125000005907 alkyl ester group Chemical group 0.000 description 1
- 125000004414 alkyl thio group Chemical group 0.000 description 1
- RMRFFCXPLWYOOY-UHFFFAOYSA-N allyl radical Chemical compound [CH2]C=C RMRFFCXPLWYOOY-UHFFFAOYSA-N 0.000 description 1
- 125000005336 allyloxy group Chemical group 0.000 description 1
- HTKFORQRBXIQHD-UHFFFAOYSA-N allylthiourea Chemical compound NC(=S)NCC=C HTKFORQRBXIQHD-UHFFFAOYSA-N 0.000 description 1
- DIZPMCHEQGEION-UHFFFAOYSA-H aluminium sulfate (anhydrous) Chemical compound [Al+3].[Al+3].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O DIZPMCHEQGEION-UHFFFAOYSA-H 0.000 description 1
- XYXNTHIYBIDHGM-UHFFFAOYSA-N ammonium thiosulfate Chemical compound [NH4+].[NH4+].[O-]S([O-])(=O)=S XYXNTHIYBIDHGM-UHFFFAOYSA-N 0.000 description 1
- 150000001449 anionic compounds Chemical class 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 239000002216 antistatic agent Substances 0.000 description 1
- 125000003710 aryl alkyl group Chemical group 0.000 description 1
- 125000001769 aryl amino group Chemical group 0.000 description 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 description 1
- 125000005110 aryl thio group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 239000012752 auxiliary agent Substances 0.000 description 1
- QVQLCTNNEUAWMS-UHFFFAOYSA-N barium oxide Chemical compound [Ba]=O QVQLCTNNEUAWMS-UHFFFAOYSA-N 0.000 description 1
- 229910001864 baryta Inorganic materials 0.000 description 1
- 150000001565 benzotriazoles Chemical class 0.000 description 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 150000001661 cadmium Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 125000006364 carbonyl oxy methylene group Chemical group [H]C([H])([*:2])OC([*:1])=O 0.000 description 1
- 125000005708 carbonyloxy group Chemical group [*:2]OC([*:1])=O 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 239000003518 caustics Substances 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- NEHMKBQYUWJMIP-NJFSPNSNSA-N chloro(114C)methane Chemical compound [14CH3]Cl NEHMKBQYUWJMIP-NJFSPNSNSA-N 0.000 description 1
- WBLIXGSTEMXDSM-UHFFFAOYSA-N chloromethane Chemical compound Cl[CH2] WBLIXGSTEMXDSM-UHFFFAOYSA-N 0.000 description 1
- 239000013256 coordination polymer Substances 0.000 description 1
- 125000004093 cyano group Chemical group *C#N 0.000 description 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 1
- 238000011033 desalting Methods 0.000 description 1
- 150000004683 dihydrates Chemical class 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 125000003754 ethoxycarbonyl group Chemical group C(=O)(OCC)* 0.000 description 1
- 125000002541 furyl group Chemical group 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 150000002503 iridium Chemical class 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- 239000004816 latex Substances 0.000 description 1
- 229920000126 latex Polymers 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- VSEAAEQOQBMPQF-UHFFFAOYSA-N morpholin-3-one Chemical group O=C1COCCN1 VSEAAEQOQBMPQF-UHFFFAOYSA-N 0.000 description 1
- 125000002757 morpholinyl group Chemical group 0.000 description 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 description 1
- 229920001220 nitrocellulos Polymers 0.000 description 1
- 229910000510 noble metal Inorganic materials 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000003431 oxalo group Chemical group 0.000 description 1
- 125000003452 oxalyl group Chemical group *C(=O)C(*)=O 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 125000002255 pentenyl group Chemical group C(=CCCC)* 0.000 description 1
- 125000005981 pentynyl group Chemical group 0.000 description 1
- CMCWWLVWPDLCRM-UHFFFAOYSA-N phenidone Chemical compound N1C(=O)CCN1C1=CC=CC=C1 CMCWWLVWPDLCRM-UHFFFAOYSA-N 0.000 description 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 description 1
- 125000006678 phenoxycarbonyl group Chemical group 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 125000004437 phosphorous atom Chemical group 0.000 description 1
- 238000000206 photolithography Methods 0.000 description 1
- 125000004193 piperazinyl group Chemical group 0.000 description 1
- 239000004014 plasticizer Substances 0.000 description 1
- 229920000233 poly(alkylene oxides) Polymers 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920006267 polyester film Polymers 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- BHZRJJOHZFYXTO-UHFFFAOYSA-L potassium sulfite Chemical compound [K+].[K+].[O-]S([O-])=O BHZRJJOHZFYXTO-UHFFFAOYSA-L 0.000 description 1
- 235000019252 potassium sulphite Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 description 1
- NDGRWYRVNANFNB-UHFFFAOYSA-N pyrazolidin-3-one Chemical class O=C1CCNN1 NDGRWYRVNANFNB-UHFFFAOYSA-N 0.000 description 1
- USPWKWBDZOARPV-UHFFFAOYSA-N pyrazolidine Chemical compound C1CNNC1 USPWKWBDZOARPV-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 125000001308 pyruvoyl group Chemical group O=C([*])C(=O)C([H])([H])[H] 0.000 description 1
- 150000003283 rhodium Chemical class 0.000 description 1
- 239000010948 rhodium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- IYKVLICPFCEZOF-UHFFFAOYSA-N selenourea Chemical compound NC(N)=[Se] IYKVLICPFCEZOF-UHFFFAOYSA-N 0.000 description 1
- HKZLPVFGJNLROG-UHFFFAOYSA-M silver monochloride Chemical compound [Cl-].[Ag+] HKZLPVFGJNLROG-UHFFFAOYSA-M 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 229940087562 sodium acetate trihydrate Drugs 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960000999 sodium citrate dihydrate Drugs 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 1
- 235000019345 sodium thiosulphate Nutrition 0.000 description 1
- HLWRUJAIJJEZDL-UHFFFAOYSA-M sodium;2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetate Chemical compound [Na+].OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC([O-])=O HLWRUJAIJJEZDL-UHFFFAOYSA-M 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- HXJUTPCZVOIRIF-UHFFFAOYSA-N sulfolane Chemical group O=S1(=O)CCCC1 HXJUTPCZVOIRIF-UHFFFAOYSA-N 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003718 tetrahydrofuranyl group Chemical group 0.000 description 1
- 125000005958 tetrahydrothienyl group Chemical group 0.000 description 1
- 125000000383 tetramethylene group Chemical group [H]C([H])([*:1])C([H])([H])C([H])([H])C([H])([H])[*:2] 0.000 description 1
- 150000003475 thallium Chemical class 0.000 description 1
- 125000001544 thienyl group Chemical group 0.000 description 1
- 125000001391 thioamide group Chemical group 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 125000001425 triazolyl group Chemical group 0.000 description 1
- 125000004044 trifluoroacetyl group Chemical group FC(C(=O)*)(F)F 0.000 description 1
- 125000004205 trifluoroethyl group Chemical group [H]C([H])(*)C(F)(F)F 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229910000406 trisodium phosphate Inorganic materials 0.000 description 1
- 235000019801 trisodium phosphate Nutrition 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- 229910052724 xenon Inorganic materials 0.000 description 1
- FHNFHKCVQCLJFQ-UHFFFAOYSA-N xenon atom Chemical compound [Xe] FHNFHKCVQCLJFQ-UHFFFAOYSA-N 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、支持体上にハロゲン化銀感光層を有する写真
感光材料に関し、更に詳しくは高コントラストが得られ
るハロゲン化銀写真感光材料に関する。DETAILED DESCRIPTION OF THE INVENTION [Industrial Field of Application] The present invention relates to a photographic material having a silver halide photosensitive layer on a support, and more particularly to a silver halide photographic material capable of providing high contrast.
写真製版工程では連続調の原稿を網点画像に変換する工
程か含まれる。この工程には、超硬調の画像再現をなし
得る写真技術として伝染現像による技術が用いられてき
た。The photolithography process involves converting a continuous tone original into a halftone image. In this process, contagious development has been used as a photographic technique capable of reproducing ultra-high contrast images.
伝染現像に用いられるリス型ハロゲン化銀写真感光材料
は、例えば平均粒子径が0.2μmで粒子分布が狭く粒
子の形も揃っていて、かつ塩化銀の含有率の高い(少な
くとも50モル%以上)塩臭化銀乳剤よりなる。このリ
ス型ハロゲン化銀写真感光材料を亜硫酸イオン濃度か低
いアルカリ性ハイドロキノン現像液で処理することによ
り高いコントラスト、高鮮鋭度、高解像力の画像か得ら
れる。The lithium-type silver halide photographic material used for infectious development has, for example, an average grain size of 0.2 μm, a narrow grain distribution and uniform grain shape, and a high silver chloride content (at least 50 mol% or more). ) Consisting of a silver chlorobromide emulsion. By processing this lithium-type silver halide photographic light-sensitive material with an alkaline hydroquinone developer having a low sulfite ion concentration, images with high contrast, high sharpness, and high resolution can be obtained.
しかしながら、これらのリスを現像液は空気酸化を受け
やすいことがら保恒性が極めて悪いため、連続使用の際
においても、現像品質を一定に保つことは難しい。However, these developing solutions are susceptible to air oxidation and have extremely poor storage stability, making it difficult to maintain constant development quality even during continuous use.
上記のリス型現像液を使わずに迅速に、かつ高コントラ
ストの画像を得る方法か知られている。A method for quickly obtaining high-contrast images without using the above-mentioned Lith type developer is known.
例えば米国特許第2,419,975号、特開昭51−
16623号及び同51−20921号、同56−10
6244号等に見られるように、ハロゲン化銀感光材料
中にヒドラジン誘導体を含有せしめるものである。For example, U.S. Patent No. 2,419,975, JP-A-51-
No. 16623 and No. 51-20921, No. 56-10
As seen in No. 6244, etc., a hydrazine derivative is contained in a silver halide photosensitive material.
これらの方法によれは、現像液中に亜硫酸イオン濃度を
高く保つことかでき、保恒性を高めた状態で処理するこ
とができる。With these methods, it is possible to maintain a high sulfite ion concentration in the developing solution, and it is possible to process with improved preservation.
しかしながら、これらの方法では、ヒドラジン誘導体の
硬調性を充分発揮させるためにpl(11以上のpHを
有する現像液で処理しなけれはならなかった。p)11
1以上の高いpHを有する現像液は、空気にふれると現
像主薬が酸化しやすいリス現像液よりは安定であるか、
現像主薬の酸化によって、しはしは超硬調な画像が得ら
れないことかある。However, in these methods, in order to fully exhibit the high contrast properties of hydrazine derivatives, it was necessary to process with a developer having a pH of 11 or higher.
Is a developer with a high pH of 1 or more more stable than a lithium developer, in which the developing agent tends to oxidize when exposed to air?
Due to oxidation of the developing agent, ultra-high contrast images may not be obtained.
この欠点を補うために特開昭63−29751号及びヨ
ロッパ特許333,435号、同345.025号には
、比較的低pHの現像液でも硬調化する硬調化剤を含む
ハロゲン化銀写真感光材料が開示されている。In order to compensate for this drawback, Japanese Patent Application Laid-open No. 63-29751 and European Patent No. 333,435 and European Patent No. 345.025 disclose silver halide photographic sensitizers containing a high contrast agent that can achieve high contrast even in relatively low pH developing solutions. Materials are disclosed.
しかし、これらのような硬調化剤を含むハロゲン化銀写
真感光材料をpH11未満の現像液で処理した場合、硬
調化が不充分であり、満足な網点性能が得られないのが
現状である。However, when silver halide photographic light-sensitive materials containing high contrast agents such as these are processed with a developer having a pH of less than 11, the present situation is that the high contrast is insufficient and satisfactory halftone dot performance cannot be obtained. .
一方、ヨーロッパ特許364166号及び特開昭62−
222241号、同60−140340号、同62−2
50439号、同62280733号等には硬調化を促
進する為の造核促進剤か記載されており、確かにこれら
の化合物を乳剤層に添加することにより、網点性能は良
くなるが、網点中に砂状、ビン状のカブリいわゆる黒ピ
ンが発生して網点画像の品質を損なうという問題点を生
ずることがわかった。On the other hand, European Patent No. 364166 and JP-A-62-
No. 222241, No. 60-140340, No. 62-2
No. 50439, No. 62280733, etc. describe nucleation accelerators to promote high contrast, and it is true that adding these compounds to the emulsion layer improves halftone dot performance, but It has been found that sand-like or bottle-like fog, so-called black pins, occur in the film, causing a problem in which the quality of the halftone dot image is impaired.
従って、上記のような問題を解決した、有効な硬調化剤
及び造核促進剤を用いた感光材料が望まれている。Therefore, there is a need for a photosensitive material using an effective contrast enhancer and nucleation accelerator that solves the above-mentioned problems.
本発明の目的は、pH11未満の現像液で処理しても硬
調な写真特性を有すると共に、網点画像中に発生するカ
ブリを抑制して良好な網点性能を有するハロゲン化銀写
真感光材料を提供することJこある。An object of the present invention is to provide a silver halide photographic material that has high contrast photographic properties even when processed with a developer having a pH of less than 11, and also has good halftone dot performance by suppressing fog that occurs in halftone images. There is so much to offer.
本発明の上記目的は、下記構成のハロゲン化銀写真感光
材料により達成された。The above objects of the present invention have been achieved by a silver halide photographic material having the following structure.
即ち、少なくとも1層のハロゲン化銀乳剤層を有するハ
ロゲン化銀写真感光材料において、下記一般式〔A〕で
表されるヒドラジン化合物を少なくとも1種含有し、か
つアミン化合物、ヒドラジン化合物、四級オニウム塩化
合物から選はれる少なくとも1種の造核促進化合物を含
有することを特徴とするハロゲン化銀写真感光材料によ
って、上記目的は達成された。That is, a silver halide photographic material having at least one silver halide emulsion layer contains at least one hydrazine compound represented by the following general formula [A], and contains an amine compound, a hydrazine compound, and a quaternary onium. The above object has been achieved by a silver halide photographic material containing at least one nucleation-promoting compound selected from salt compounds.
一般式(,1
O
(R−(0米÷「Ar−NHNH−C−C−X式中、A
rはアリール基を表し、Xは−NR,R2又は−0R1
を表し、R1及びR2は各々、水素原子、アルキル基、
アルケニル基、アルキニル基、アリール基、複素環基、
ヒドロキンル基、アルコキシ基、アルケニルオキシ基、
アルキニルオキン基、アリールオキシ基又は複素環オキ
ン基を表しRとR2は窒素原子と共に環を形成してもよ
い。General formula (,1 O (R-(0 US ÷ "Ar-NHNH-C-C-X, where A
r represents an aryl group, and X is -NR, R2 or -0R1
, R1 and R2 are each a hydrogen atom, an alkyl group,
alkenyl group, alkynyl group, aryl group, heterocyclic group,
Hydroquinyl group, alkoxy group, alkenyloxy group,
It represents an alkynylokyne group, an aryloxy group, or a heterocyclicokyne group, and R and R2 may form a ring together with the nitrogen atom.
R3は水素原子、アルキル基、アルケニル基、アルキニ
ル基、アリール基又は複素環基を表す。R3 represents a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group or a heterocyclic group.
Rは水素原子又はアルキル基を表し、nは0又は1を表
し、mは1〜3の整数を表す。R represents a hydrogen atom or an alkyl group, n represents 0 or 1, and m represents an integer of 1 to 3.
ただし、一般式CADIで表される化合物中、少なくと
も一つのRはハロゲン化銀への吸着促進基を有するか、
又は、分子中のRの合計として耐拡散性を付与するもの
とする。However, in the compound represented by the general formula CADI, at least one R has a group that promotes adsorption to silver halide, or
Alternatively, diffusion resistance shall be imparted as the sum of R in the molecule.
般式〔A〕で表される化合物には、式中のN1(NH−
の少なくともいずれかのHが置換基で置換されたものを
含む。In the compound represented by the general formula [A], N1 (NH-
includes those in which at least one of H is substituted with a substituent.
一般式〔A〕について更に詳しく説明すると、Arは、
アリール基(例えばフェニル、ナフチル等)を表す。To explain the general formula [A] in more detail, Ar is
Represents an aryl group (eg phenyl, naphthyl, etc.).
R1及びR2は各々、水素原子、アルキル基(例えばメ
チル、エチル、メトキシエチル、シアンエチル、ヒドロ
キンエチル、4− (2,4−ジ−t−アミルフェノキ
シ)ブチル、ベンジル、トリフルオロエチル等)、アル
ケニル基(例えばアリル、ブテニル、ペンテニル、ペン
タジェニル等)、アルキニル基(例えば、グロパルギル
、ブチニル、ペンチニル等)、アリール基(例えばフェ
ニル、ナフチル、/アノフェニル、メトキシフェニル等
)、複素環基(例えばピリジン、チオフェン、7ランの
ような不飽和複素環基又はテトラヒドロフラン、スルホ
ラン、2,2,6.6−チトラメチルビペリジンのよう
な飽和複素環基)、ヒドロキシル基、アルコキシ基(例
えばメトキシ、エトキシ、ペンジルオキン、シアノメト
キシ等)、アルケニルオキシ基(例えばアリルオキシ、
ブテニルオキシ等)、アルキニルオキシ基(例えばグロ
パルギルオキシ、ブチニルオキシ等)、アリールオキシ
基(例えばフェノキシ、ナフチルオキシ等)又は複素環
オキシ基(例えばピリジルオキシ、ピリミジルオキシ等
)を表し、R1とR2は窒素原子と共に環(例えハヒペ
リジン、ピペラジン、モルホリン等)を形成してもよい
。R1 and R2 are each a hydrogen atom, an alkyl group (e.g. methyl, ethyl, methoxyethyl, cyanethyl, hydroquinethyl, 4-(2,4-di-t-amylphenoxy)butyl, benzyl, trifluoroethyl, etc.) , alkenyl groups (e.g. allyl, butenyl, pentenyl, pentagenyl, etc.), alkynyl groups (e.g. glopargyl, butynyl, pentynyl, etc.), aryl groups (e.g. phenyl, naphthyl, /anophenyl, methoxyphenyl, etc.), heterocyclic groups (e.g. pyridine). , thiophene, 7rane or saturated heterocyclic groups such as tetrahydrofuran, sulfolane, 2,2,6,6-titramethylbiperidine), hydroxyl groups, alkoxy groups (e.g. methoxy, ethoxy , penzyluoquine, cyanomethoxy, etc.), alkenyloxy groups (e.g. allyloxy,
R1 and R2 represent nitrogen Together with the atoms, they may form a ring (eg, hahyperidine, piperazine, morpholine, etc.).
R3の表すアルキル基、アルケニル基、アルキニル基、
アリール基及び複素環基としては、具体的には上述のR
,及びR2で挙げたものと同様の基が挙げられる。an alkyl group, an alkenyl group, an alkynyl group represented by R3,
As the aryl group and the heterocyclic group, specifically, the above-mentioned R
, and the same groups as those listed for R2.
Rの表すアルキル基としては、例えばメチル、エチル、
プロピル、ブチル、ベンジル等の6基が挙げられる。Examples of the alkyl group represented by R include methyl, ethyl,
Six groups include propyl, butyl, benzyl and the like.
Rの表すアルキル基には種々の置換基が導入できるが、
このような基としては、例えはカルバモイル基、ウレイ
ドカルボニル基、オキシカルボニル基、アンルアミノ基
、スルホンアミド基、カルボニルオキシ基、スルファモ
イル基等が挙げられる。Various substituents can be introduced into the alkyl group represented by R, but
Examples of such groups include carbamoyl group, ureidocarbonyl group, oxycarbonyl group, anrulamino group, sulfonamido group, carbonyloxy group, sulfamoyl group, and the like.
これらの置換基を介して耐拡散基又はノ・ロゲン化銀吸
着促進基を導入することができる。A diffusion-resistant group or a silver halide adsorption-promoting group can be introduced through these substituents.
耐拡散基としてはカプラー等の不動性写真用添加剤にお
いて常用されているバラスト基が好ましい。The diffusion-resistant group is preferably a ballast group commonly used in immobile photographic additives such as couplers.
バラスト基は8以上の炭素数を有する写真性に対して比
較的不活性な基であり、例えばアルキル基、アルコキシ
基、フェニル基、アルキル7エ二ル基、フェノキシ基、
アルキルフェノキシ基などの中から選ぶことができる。A ballast group is a group having a carbon number of 8 or more and is relatively inert to photography, such as an alkyl group, an alkoxy group, a phenyl group, an alkyl 7-enyl group, a phenoxy group,
It can be selected from alkylphenoxy groups, etc.
R−(○)n−基が分子中に複数個ある場合は、R基の
合計として(全体として)耐拡散性を付与するものであ
ればよい。When there are a plurality of R-(◯)n- groups in the molecule, it is sufficient that the sum of the R groups (as a whole) imparts diffusion resistance.
ハロゲン化銀吸着促進基としてはチオ尿素基、チオウレ
タン基、複素環チオアミド基、メルカプト複素環基、ト
リアゾール基などの米国特許4,385.108号に記
載された基が挙げられる。Examples of the silver halide adsorption promoting group include groups described in US Pat. No. 4,385.108, such as a thiourea group, a thiourethane group, a heterocyclic thioamide group, a mercapto heterocyclic group, and a triazole group.
Arで表されるアリール基には種々の置換基が導入でき
る。導入できる置換基としては、例えばハロゲン原子な
らびにアルキル、アリール、アルコキシ、アリールオキ
シ、アシルオキシ、アルキルチオ、アリールチオ、スル
ホニル、アルコキシカルボニル、アリールオキシカルボ
ニル、カルバモイル、スルファモイル、アシル、アミノ
、アルキルアミノ、アリールアミノ、アシルアミノ、ス
ルホンアミド、アリールアミノチオカルボニルアミノ、
ヒドロキシル、カルボキシル、スルホ、ニトロ、シアノ
などの基が挙げられる。Various substituents can be introduced into the aryl group represented by Ar. Examples of substituents that can be introduced include halogen atoms, alkyl, aryl, alkoxy, aryloxy, acyloxy, alkylthio, arylthio, sulfonyl, alkoxycarbonyl, aryloxycarbonyl, carbamoyl, sulfamoyl, acyl, amino, alkylamino, arylamino, and acylamino. , sulfonamide, arylaminothiocarbonylamino,
Examples include groups such as hydroxyl, carboxyl, sulfo, nitro, and cyano.
一般式[A)中の−NHNH−のN1即ちヒドラジンの
水素原子は、スルホニル基(例えばメタンスルホニル、
トルエンスルホニル等)、アシル基(例えば、アセチル
、トリフルオロアセチル、エトキシカルボニル等)、オ
キザリル基(例えば、工トキザリル、ピルボイル等)等
の置換基で置換されていてもよく、一般式[A)で表さ
れる化合物はこのようなものも含む。In the general formula [A), N1 of -NHNH-, that is, the hydrogen atom of hydrazine, is a sulfonyl group (e.g. methanesulfonyl,
(toluenesulfonyl, etc.), an acyl group (e.g., acetyl, trifluoroacetyl, ethoxycarbonyl, etc.), an oxalyl group (e.g., oxalyl, pyruvoyl, etc.); The compounds represented also include such compounds.
本発明において、より好ましい化合物(ツ、一般式(A
)中のR1及びR2のうち少なくとも一方がアルケニル
基、アルキニル基、飽和複素環基、ヒドロキシル基又は
アルコキシ基を表すか、R1がアルキニル基又は飽和複
素環基を表す化合物である。In the present invention, more preferred compounds (2, general formula (A
) in which at least one of R1 and R2 represents an alkenyl group, an alkynyl group, a saturated heterocyclic group, a hydroxyl group, or an alkoxy group, or a compound in which R1 represents an alkynyl group or a saturated heterocyclic group.
上記一般式[A)で表される化合物の代表的具体例を以
下に示すが、本発明はこれらに限定されし3n7
CH2Cl、5H
CH2CH2CH,SH
本発明に係る一般式〔A〕で表される化合物は、英国特
許2.011.391号、米国特許4.686.167
号、ヨーロッパ特許301,799号、特開昭62−1
80361号公報、同62−178246号等に記載の
合成法に準して容易に合成することができる。Typical specific examples of the compound represented by the above general formula [A] are shown below, but the present invention is not limited thereto. The compound is described in British Patent No. 2.011.391 and US Patent No. 4.686.167.
No., European Patent No. 301,799, JP-A-62-1
It can be easily synthesized according to the synthesis method described in JP-A No. 80361, No. 62-178246, and the like.
例えば、前記例示化合物(1)は、次の方法で合成する
ことかできる。For example, the exemplary compound (1) can be synthesized by the following method.
化合物(13)は次の方法で合成することかできる。Compound (13) can be synthesized by the following method.
る。この中で好ましい化合物としては、(V)−1゜〔
■〕−II、 〔V)−11[、CVT)−I 、 (
Vl)−II、 (Vl)−■の化合物が挙げられる。Ru. Among these, preferred compounds include (V)-1゜[
■]-II, [V)-11[,CVT)-I, (
Examples include the compounds Vl)-II and (Vl)-■.
一般式CI) その他の化合物も同様に合成することができる。General formula CI) Other compounds can be similarly synthesized.
本発明において一般式〔A〕で表される化合物と併用さ
れる造核促進化合物のアミン化合物、ヒドラジン化合物
、四級オニウム塩化合物としては、下記の一般式〔I)
〜〔VI)の化合物が挙げられRr 、 R2、Rsは
水素原子又は置換基表す。R3R2,R3は互いに連結
して環を形成してもよい。In the present invention, the amine compound, hydrazine compound, and quaternary onium salt compound of the nucleation promoting compound to be used in combination with the compound represented by the general formula [A] is represented by the following general formula [I].
- [VI) Compounds are mentioned, and Rr, R2, and Rs represent a hydrogen atom or a substituent. R3R2 and R3 may be linked to each other to form a ring.
R、、R2,R、が表す置換基としては、例えばアルキ
ル基(例えばメチル、エチル、プロピル、ブチル、ヘキ
シル、シクロヘキシル等の基)、アルケニル基(例えば
アリル、ブテニル等の基)、アルキニル基(例えばプロ
パルギル、ブチニル等の基)、アリール基(例えばフェ
ニル、ナフチル等の基)、ヘテロ環基(例えばピペリジ
ニル、ピペラジニル、モルホリニル、ピリジル、フリル
、チエニル、テトラヒドロフリル、テトラヒドロチエニ
ル、スルホラニル等の基)が挙げられる。Examples of the substituents represented by R, R2, R include alkyl groups (for example, methyl, ethyl, propyl, butyl, hexyl, cyclohexyl, etc.), alkenyl groups (for example, allyl, butenyl, etc.), alkynyl groups ( (e.g., propargyl, butynyl, etc.), aryl groups (e.g., phenyl, naphthyl, etc.), heterocyclic groups (e.g., piperidinyl, piperazinyl, morpholinyl, pyridyl, furyl, thienyl, tetrahydrofuryl, tetrahydrothienyl, sulfolanyl, etc.) Can be mentioned.
R、、R、、R、が互いに連結して形成してもよい環と
しては、例えばピペリジン、モルホリン、ピペラジン、
キヌクリジン、ピリジン等の環が挙げられる。Examples of the ring that R, , R, , R may be formed by linking each other include piperidine, morpholine, piperazine,
Examples include rings such as quinuclidine and pyridine.
R、、R2,R、で表される基には更に置換基(例えば
ヒドロキンル、アルコキン、アリールオキシ、カルポキ
ンル、スルホ、アルキル、アリール等の基)か置換して
いてもよい。R、、R2,R、としては水素原子及びア
ルキル基が好ましい。The groups represented by R, R2, R, may be further substituted with a substituent (for example, a group such as hydroquine, alkoxy, aryloxy, carpoquine, sulfo, alkyl, aryl, etc.). R, , R2, R are preferably a hydrogen atom or an alkyl group.
以下に代表的具体例を示す。Typical specific examples are shown below.
I−I l−2
(C2Hs)2NcH2cFlzcI(zOHC83N
)ICH2CH20HI−3l−4
(C2H5)2NC)12CH20f((CzH5)2
NCH2C1(CH20)1H
I−5、1−6
■
(C+H*)2NcHzcHzo)l
(C,H,)2NCH2CHCH20HH
■
■ −14
■
■ −16
■
■
■
(i−C31h)2NH
■
C+HsN(CHaCH20H) 2
■
(Ph−CH2)2NCH2CH,OH■
(C1l)117)2NCH2CH20H■
(C+Jx、)2Nc82GHzOH
一般式(II)
R2−、Q−R。I-I l-2 (C2Hs)2NcH2cFlzcI (zOHC83N
)ICH2CH20HI-3l-4 (C2H5)2NC)12CH20f((CzH5)2
NCH2C1(CH20)1H I-5, 1-6 ■ (C+H*)2NcHzcHzo)l (C,H,)2NCH2CHCH20HH ■ ■ -14 ■ ■ -16 ■ ■ ■ (i-C31h)2NH ■ C+HsN (CHaCH20H) 2 ■ (Ph-CH2)2NCH2CH,OH■ (C1l)117)2NCH2CH20H■ (C+Jx,)2Nc82GHzOH General formula (II) R2-, Q-R.
I Xo
QはN又はP原子を表し、RI+ R2+ R3+ R
4は各々、水素原子又は置換可能な基を表す。Xoはア
ニオンを表す。R,、R,、R,、R,は互いに連結し
て環を形成してもよい。I Xo Q represents N or P atom, RI+ R2+ R3+ R
4 each represents a hydrogen atom or a substitutable group. Xo represents an anion. R,, R,, R,, R, may be connected to each other to form a ring.
R,、R2,R,、R,で表される置換可能な基として
は、例えばアルキル、アルケニル、アルキール、アリー
ル、ペテロ環、アミノ等の6基か挙げられ、具体的には
一般式(1)のR,、R2,R3゜で説明したものが挙
げられる。Examples of substitutable groups represented by R, R2, R, and R include six groups such as alkyl, alkenyl, alkyl, aryl, petero ring, and amino. ), those explained for R,, R2, R3° can be mentioned.
Rl+ R2+ Rs、Raが形成し得る環としては、
一般式CI)のR,、R2,R,で形成し得る環として
説明したものと同様のものが挙げられる。Rings that Rl+ R2+ Rs and Ra can form include:
Examples of the ring that can be formed by R,, R2, and R in the general formula CI) include the same rings as those described above.
X8か表すアニオンとしては、ハロゲノ化物イオン、硫
酸イオン、硝酸イオン、酢酸イオン、パラトルエンスル
ホン酪イオン等の無機及び有機のアニオンか挙げられる
。Examples of the anion represented by X8 include inorganic and organic anions such as halide ions, sulfate ions, nitrate ions, acetate ions, and paratoluenesulfonbutyric ions.
以下に代表的具体例を示す。Typical specific examples are shown below.
It−I I[−2
Ph CH2N(CHI)I CQeC161(3
1N(CIll)I Br’Ph CH2N(C
H3)2 CQ0督
c、 482 e
CI2H250Ph CH2N(CHs)x C
(10t−9
(UzHs〕3N(にH2)aN(に2Hs)32シQ
″:′
CH2C1(2−Ph
r0
■
CHzCOOCJ
CH2Ph N)IcOcs)In
■
■
CQe
CHxCH200C(CH2)+COOCfbCHx一
般式CIII)
■
(CJs)+pe
CI 6H33
Br0
Br’
R、、R2はアルキル基を表し、R1とR2は連結して
環を形成してもよい。R1はアルキル基、アリール基、
ヘテロ環基を表し、Aはアルキレン基を表す。It-I I[-2 Ph CH2N(CHI)I CQeC161(3
1N(CIll)I Br'Ph CH2N(C
H3) 2 CQ0 Director c, 482 e CI2H250Ph CH2N(CHs) x C
(10t-9 (UzHs) 3N (H2) aN (2Hs) 32Q
'':' CH2C1(2-Ph r0 ■ CHzCOOCJ CH2Ph N) IcOcs)In ■ ■ CQe CHxCH200C(CH2)+COOCfbCHx General formula CIII) ■ (CJs)+pe CI 6H33 Br0 Br' R,, R2 represents an alkyl group, R 1 and R2 may be linked to form a ring.R1 is an alkyl group, an aryl group,
It represents a heterocyclic group, and A represents an alkylene group.
Yは一〇〇NR,−、−0CONR,−,−NR,C0
NR4−、−NR,Coo−。Y is 100NR, -, -0CONR, -, -NR, C0
NR4-, -NR,Coo-.
coo−−oco−、〜Co−,−0COO−、−NR
,CO−、−502NR。coo--oco-, ~Co-, -0COO-, -NR
, CO-, -502NR.
NRISO2−、NR45O□NR,−、−3O2−、
−3−、−0−、NR。NRISO2-, NR45O□NR,-, -3O2-,
-3-, -0-, NR.
N= 基を表し、R4は水素原子又はアルキル基を表す
。N= represents a group, and R4 represents a hydrogen atom or an alkyl group.
R8,R2で表されるアルキル基としては、一般式〔■
〕で説明したR l、R2,R1のアルキル基と同様の
ものか挙げられ、R1とR2で形成し得る環も同様のも
のか挙げられる。As the alkyl group represented by R8 and R2, the general formula [■
Examples include the same alkyl groups as Rl, R2, and R1 explained above, and examples of the ring that can be formed by R1 and R2 include the same alkyl groups.
R3で表されるアルキル基、アリール基、ヘテロ環基も
一般式〔工〕のR、、R、、R、の表すアルキル基、ア
リール基、ヘテロ環基と同様のものが挙げられる。Examples of the alkyl group, aryl group, and heterocyclic group represented by R3 include those similar to the alkyl group, aryl group, and heterocyclic group represented by R, , R, , R in the general formula [E].
Aで表されるアルキレン基としては、例えはメチレン、
エチレン、l−リメチレン、テトラメチレン等か挙げら
れ、Aの置換基としてはアリール基、アルコキン基、ヒ
ドロキ/ル基、ハロゲン原子なとを挙げらることができ
る。Examples of the alkylene group represented by A include methylene,
Examples include ethylene, l-rimethylene, and tetramethylene, and examples of substituents for A include aryl groups, alkokene groups, hydroxyl groups, and halogen atoms.
R,で表されるアルキル基は、炭素数1〜5の低級アル
キル基又はアラルキル基(例えはベンジル基なと)か好
ましい。The alkyl group represented by R is preferably a lower alkyl group having 1 to 5 carbon atoms or an aralkyl group (eg, benzyl group).
以下に代表的具体例を示す。Typical specific examples are shown below.
■
(C2H5)2N(CH2)2NHCOC13H27(
CH3)2N(CH2)2CONHC14H29(C2
Hi)2N(CH2)3NHcONHc+28.s■−
12
cso++(t)
■
(CIHs)2N(CHz)zOcON)ICeH+
7(C,R9)2N(CH2)3NH502N(CH2
Ph)。■ (C2H5)2N(CH2)2NHCOC13H27(
CH3)2N(CH2)2CONHC14H29(C2
Hi)2N(CH2)3NHcONHc+28. s■-
12 cso++(t) ■ (CIHs)2N(CHz)zOcON)ICeH+
7(C,R9)2N(CH2)3NH502N(CH2
Ph).
■
(Pb−CH2)2N(CH2)30C,R9CH2)
2N((Jh)2NHs02N(CH>’h0C1□H
2S
■
C3H7(i)
しR2
一般式(TV)
TV−4
R、、R2は水素原子、アルキル基、アルケニル基、ア
ルキニル基、アリール基、ヘテロ環基を表し、R1,R
2,Eで環を形成してもよい。■ (Pb-CH2)2N(CH2)30C,R9CH2)
2N((Jh)2NHs02N(CH>'h0C1□H
2S ■ C3H7(i) R2 General formula (TV) TV-4 R,, R2 represents a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heterocyclic group, and R1, R
2,E may form a ring.
Eは(CH2CH20iで表される基を少なくとも一つ
含む基であるり、nは2以上の整数を表す。E is a group containing at least one group represented by (CH2CH20i, and n represents an integer of 2 or more.
R、、R、で表されるアルキル基、アルケニル基、アル
キニル基、アリール基、ヘテロ環基及びR1゜R2,E
で形成し得る環としては、一般式CI〕のR+ 、 R
2、R3で説明したものと同様のものが挙げられる。Alkyl group, alkenyl group, alkynyl group, aryl group, heterocyclic group represented by R, ,R, and R1゜R2,E
Examples of the ring that can be formed include R+ of general formula CI], R
2. The same ones as those explained in R3 can be mentioned.
以下に代表的具体例を示す。Typical specific examples are shown below.
TV−1
TV−5
(C4)19)2N(CH2CH20)3HV−6
(C2H5)2N(CR2CH2O)〜、、CH2CH
2N(C2H5)IC,R7)2N(CH,CH20)
、CI(2C82N(C3H。TV-1 TV-5 (C4)19)2N(CH2CH20)3HV-6 (C2H5)2N(CR2CH2O)~,,CH2CH
2N(C2H5)IC,R7)2N(CH,CH20)
, CI(2C82N(C3H.
TV −10
(C2Hs)2N(CH2CH20)〜3zcH2cH
2N(C2Hs)2(i −C3H7)2N(CH2C
H20)〜6H■−2
(C3H+)2N(CH2CH20)〜scHzcH2
N(CsHy)2(CJ7)xN(CH3CH20)i
f(■
(C+H+)2N(01zC)I20)〜、 、CH2
CH2N(C1l(7)2C[(: =CFIC)12
NH(CH2CH20)〜1.cH2cH2NHcH2
cH=cH。TV-10 (C2Hs)2N(CH2CH20)~3zcH2cH
2N(C2Hs)2(i-C3H7)2N(CH2C
H20)~6H■-2 (C3H+)2N(CH2CH20)~scHzcH2
N(CsHy)2(CJ7)xN(CH3CH20)i
f(■ (C+H+)2N(01zC)I20)~, ,CH2
CH2N(C1l(7)2C[(: =CFIC)12
NH(CH2CH20)~1. cH2cH2NHcH2
cH=cH.
■
CI(二CC82NH(CI(2CH20)〜+ *C
HzCH2NHCH2CミCI((C3H7)2N(C
H2CH20)〜32CH2CH2N(C3H+)2(
CIF!9)2N(CH2CH20)〜s C)] 2
CH2N (Ct H+ ) 2■
(C,H,)2N(CH20H20)21((C,Hり
2N(CH2C1(20)〜、 、CH2CH2N(C
,I(、)2■
(c、o、 7)2N(CH2CH2O)28■
(CHx)2cHcH*c)INH(CHzCH20)
〜+ tcH2cH2NHcHct(、CH(CHx)
2(CンaHss’1zNccHzcHzo’)xH■
(Ph CH2)J(CHzCHzO)J(CHx)
2CH(CH2)xcHNH(CH2CH20)〜+
a CH2CH2NHCHCH(CH2) i CH(
C83) 2■
(C4Ht)2N(CH20H20)2cHzcHzN
(CnHs)zCsH+ +NH(CH2CH20)〜
、 、CHICH,NHC5H。■ CI(2CC82NH(CI(2CH20)~+ *C
HzCH2NHCH2C MiCI((C3H7)2N(C
H2CH20) ~ 32CH2CH2N(C3H+)2(
CIF! 9) 2N(CH2CH20)~sC)] 2
CH2N (Ct H+ ) 2■ (C,H,)2N(CH20H20)21((C,H2N(CH2C1(20)~, ,CH2CH2N(C
,I(,)2■ (c, o, 7)2N(CH2CH2O)28■ (CHx)2cHcH*c)INH(CHzCH20)
〜+tcH2cH2NHcHct(,CH(CHx)
2(CnaHss'1zNccHzcHzo')xH■ (Ph CH2)J(CHzCHzO)J(CHx)
2CH(CH2)xcHNH(CH2CH20)〜+
a CH2CH2NHCHCH(CH2) i CH(
C83) 2■ (C4Ht)2N(CH20H20)2cHzcHzN
(CnHs)zCsH+ +NH(CH2CH20)~
, ,CHICH,NHC5H.
■
(CsH+ +)zN(CI(zcl(zo)2cHz
cH2N(Cs)It 7)2c、o、 5NH(CH
2C1(20)〜zCH2CH2NHC7H+i■
(HOCH2CH2)2N(CH2CH,0)2CH2
CH2N(C)1.c)I20H)!(HOCHzCH
2)2N(CHzCH20)〜+ IC1(2C82N
(CI(2CH20H)2一般式〔■〕−a
(CI(2= CH2CH2) zN(CI(:CH2
0)2H(CH2=CHCH2)2(CH20H20)
2CH2CH2N(CH2CH−CH2)2C6H!1
Ca!(z
COs l:H= CHC)12 N (CH2CHz
O) 2 C)12 CH2NCH2CH= CHC
H3CH,−Pb CH2−PhR、、R
2,R、はアルキル基、アルケニル基、アルキニル基、
アリール基、ヘテロ環基を示す。■ (CsH+ +)zN(CI(zcl(zo)2cHz
cH2N(Cs)It 7)2c,o,5NH(CH
2C1(20)~zCH2CH2NHC7H+i■ (HOCH2CH2)2N(CH2CH,0)2CH2
CH2N(C)1. c) I20H)! (HOCHHzCH
2) 2N (CHZCH20) ~ + IC1 (2C82N
(CI(2CH20H)2 General formula [■]-a (CI(2= CH2CH2) zN(CI(:CH2
0) 2H(CH2=CHCH2)2(CH20H20)
2CH2CH2N (CH2CH-CH2)2C6H! 1 Ca! (z COs l:H=CHC)12N (CH2CHz
O) 2 C) 12 CH2NCH2CH= CHC
H3CH,-Pb CH2-PhR,,R
2, R is an alkyl group, an alkenyl group, an alkynyl group,
Indicates an aryl group or a heterocyclic group.
但し、R、、R、、R3のうち少なくとも一つはアルケ
ニル基又はアルキニル基を表すが、又はRR2のうち少
なくとも一つはアリール基又はヘテロ環基を表すものと
する。Rr 、 R2、L 、 Rsで環を形成しても
よい。Lは連結基を表す。However, at least one of R, R, and R3 represents an alkenyl group or an alkynyl group, or at least one of RR2 represents an aryl group or a heterocyclic group. Rr, R2, L, and Rs may form a ring. L represents a linking group.
R、、R2,R、が表すアルキル基、アルケニル基、ア
ルキニル基、アリール基、ヘテロ環基としては、一般式
〔工〕のRItR!+Rsで挙げた基と同様のものが挙
げられる。The alkyl group, alkenyl group, alkynyl group, aryl group, and heterocyclic group represented by R,, R2, and R include RItR! of the general formula [E]. The same groups as those listed for +Rs can be mentioned.
R、、R、、L 、R1で形成し得る環としては、例え
はピペリジン、モルホリン、ピロリジン等のへテロ環が
挙げられる。Examples of the ring that can be formed by R, , R, , L and R1 include heterocycles such as piperidine, morpholine, and pyrrolidine.
して表される連結基としては、例えば一般式(III)
で挙げたーA−Y−が挙げられる。As a linking group represented by, for example, general formula (III)
-A-Y- mentioned above can be mentioned.
以下に代表的具体例を示す。Typical specific examples are shown below.
V−a−1
(CH3)2N(CI(z)3NICONFl(CHz
)acH−CHCaH+ y■
(C21(s ) 2N(CH2) xNHco(CH
2) yCH= CHCJ Iy−a
(C4Hs)2N(C)h)zOcONH(CHz)s
cH=cHcsH+ 7■
(CzHs)2N(CH2)3N)ICOO(CH2)
gcH=cHcaH+ 7■
■
■
−a−8
−a
■
(CHz =CI(CH2)2N(CH2)2NH5O
2N(Ph−CH2)2−a
(C4Hs)zN(CHz)3NH3O2N(CHzC
H−CHz)z−a
(Ph CHz)zN(CH2)zNH5OzN(C
I(zcH=cHz)z■
■
(C2H5)2N(C)12)30COC:CC6H,
3−a
(C2Hs)2N(CH2)2NHCOOCH2C=C
C+H+ s■
(Ph CH2)2N(CI(2)20CONHC)
l:C−CH−a−13
(Ph C112)2N(CH2)2NHcON(C
H2CH=CI(z)2■
(Ph CHz)2N(CH2)3NHcOcミCC
,H,3■
(Ph CH2)2N(CH2)2NHCOOC1(
2CH=CH2し2H5
■
−a
一般式
R、、R2,R4はアルキル基、
アルケニル基、
ア
ルキニル基、
アリール基、
ヘテロ環基を表し、
は水素原子又は置換可能な基を表1゜
Lは連結基を表し、nは0又はlの整数を表す。V-a-1 (CH3)2N(CI(z)3NICONFl(CHz
)acH−CHCaH+ y■ (C21(s) 2N(CH2) xNHco(CH
2) yCH= CHCJ Iy-a (C4Hs)2N(C)h)zOcONH(CHz)s
cH=cHcsH+ 7■ (CzHs)2N(CH2)3N)ICOO(CH2)
gcH=cHcaH+ 7 ■ ■ ■ -a-8 -a ■ (CHz = CI(CH2)2N(CH2)2NH5O
2N(Ph-CH2)2-a (C4Hs)zN(CHz)3NH3O2N(CHzC
H-CHz)z-a (Ph CHz)zN(CH2)zNH5OzN(C
I(zcH=cHz)z■■ (C2H5)2N(C)12)30COC:CC6H,
3-a (C2Hs)2N(CH2)2NHCOOCH2C=C
C+H+ s■ (Ph CH2)2N (CI(2)20CONHC)
l:C-CH-a-13 (Ph C112)2N(CH2)2NHcON(C
H2CH=CI(z)2■ (Ph CHz)2N(CH2)3NHcOcmiCC
,H,3■ (Ph CH2)2N(CH2)2NHCOOC1(
2CH=CH2 and 2H5 ■ -a General formula R, , R2, R4 represents an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heterocyclic group, and is a hydrogen atom or a substitutable group Table 1゜L is a linkage represents a group, and n represents an integer of 0 or l.
R2,R、、L 、R、で連結して環を形成してもよい
。R2, R,, L, R, may be connected to form a ring.
R、、R2,R、で表されるアルキル基、アルケニル基
、アルキニル基、アリール基、ヘテロ環基としては、一
般式〔■〕のR1,R2+R3で説明したのと同様の基
が挙げられる。Examples of the alkyl group, alkenyl group, alkynyl group, aryl group, and heterocyclic group represented by R, , R2, and R include the same groups as explained for R1, R2+R3 in the general formula [■].
R3で表される置換可能な基としては、例えはアルキル
、アルケニル、アリール、ヘテロ環等の6基であり、上
述したと同様の基が挙げられる。Examples of the substitutable group represented by R3 include six groups such as alkyl, alkenyl, aryl, and heterocycle, including the same groups as mentioned above.
Lは連結基を表すが、例えば−co−、−coo−CO
NRs 、 502 、 5O2NRs−等の基
を表す。L represents a linking group, for example -co-, -coo-CO
Represents a group such as NRs, 502, 5O2NRs-.
R6は水素原子又は置換可能な基を表す。R6 represents a hydrogen atom or a substitutable group.
R、、R2,R、、L 、R、で形成し得る環としては
、例えはピペリジン、モルホリン等のへテロ環が挙けら
れる。Examples of the ring that can be formed by R, , R2, R, , L and R include heterocycles such as piperidine and morpholine.
(CI(3)2NNH5O2C+6Hx+(C)Iz)
zNNH5O2(Ph C1(2)2ヌ−!−ノ
■
−b
−b
(CH2−Ph)2NNH3O2C,H,7■
(Ph−CH2)2N−NCOC,3H2□H2−Ph
−b
■
(CH2=CHCH2)2NNH5O2CI2H2S■
−b
■
b
■
■
−b
■
■
■
般式
%式%
R1は水素原子又は置換基を表し、R2はアルキル、ア
ルケニル、アルキニル、アリール、ヘテロ環基の6基を
表す。Lは連結基を表す。(CI(3)2NNH5O2C+6Hx+(C)Iz)
zNNH5O2(Ph C1(2)2nu-!-no■ -b -b (CH2-Ph)2NNH3O2C,H,7■ (Ph-CH2)2N-NCOC,3H2□H2-Ph -b ■ (CH2=CHCH2 )2NNH5O2CI2H2S ■ -b ■ b ■ ■ -b ■ ■ ■ General formula % Formula % R1 represents a hydrogen atom or a substituent, R2 represents 6 groups of alkyl, alkenyl, alkynyl, aryl, and heterocyclic group.L is Represents a linking group.
シ,)は含窒素へテロ環を表す。nは0又は1の整数を
表す。R1は 瞠 !と共に環を形成して゛、、−、5
′
もよい。C,) represents a nitrogen-containing heterocycle. n represents an integer of 0 or 1. R1 is Mari! form a ring with ゛,,-,5
′ is also good.
R2で表されるアルキル、アルケニル、アルキニル、ア
リール、ヘテロ環の6基としては、一般式CI)のR
l+R 2+R sで説明したものと同様の基が挙げら
れる。R1で表される基のうち置換基としては、例えば
上記R2で説明したものと同様の基が挙げられる。The six groups of alkyl, alkenyl, alkynyl, aryl, and heterocycle represented by R2 include R of the general formula CI)
l+R 2+R The same groups as those explained for s can be mentioned. Examples of the substituent in the group represented by R1 include the same groups as those explained for R2 above.
して表される連結基としては、例えば一般式CI[[)
のYで表されるものと同様のものが挙げられる。As a linking group represented by, for example, the general formula CI [[)
Examples include those similar to those represented by Y in .
以下に代表的具体例を示す。Typical specific examples are shown below.
−c
成し得るヘテロ環としては、例えばキヌクリジン、ピペ
リジン、ピラゾリジン等のへテロ環が挙げられる。-c Examples of possible heterocycles include heterocycles such as quinuclidine, piperidine, and pyrazolidine.
■ ■ ■ ■ ■ CH,CH−CH2 ■ ■ C,H。■ ■ ■ ■ ■ CH, CH-CH2 ■ ■ C,H.
■
■ −
■
■
■ −
■
■
−c
■
−c−31
−c−35
■
一般式(VI)
R、、R、はアルキル基、アルケニル基、アルキニル基
、アリール基、ヘテロ環基を表し、R1は水素原子又は
置換基を表す。■ ■ - ■ ■ ■ - ■ ■ -c ■ -c-31 -c-35 ■ General formula (VI) R, , R represent an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heterocyclic group, R1 represents a hydrogen atom or a substituent.
R4ハACHx CHX端 又ハ(CH2CHCH2
0i テ表される基を少なくとも一つ含む基である。R
は水素原子又はアルキル基を表し、Xは0.3又はNH
基を表し、Yは水素原子又はOR基を表し、nは2以上
の整数を表す。R、、R2,R1,R、で連結して環を
形成してもよい。R4ha ACHx CHX end Mataha (CH2CHCH2
Oi is a group containing at least one group represented by Te. R
represents a hydrogen atom or an alkyl group, and X is 0.3 or NH
Y represents a hydrogen atom or an OR group, and n represents an integer of 2 or more. R,, R2, R1, and R may be connected to form a ring.
R+ 、 R!で表されるアルキル基、アルケニル基、
アルキニル基、アリール基、ヘテロ環基としては、一般
式(I)のR、、R2,R、と同様の基で説明したもの
と同じものが挙げられる。R+, R! Alkyl group, alkenyl group represented by
Examples of the alkynyl group, aryl group, and heterocyclic group include the same groups as those explained for R, , R2, and R in general formula (I).
R1で表される基のうち置換基としては、例えばアルキ
ル基、アルケニル基、アルキニル基、アリール基、ヘテ
ロ環基、アシル基、スルホニル基、オキシカルボニル基
、カルバモイル基等が挙げられる。R3で表される置換
基のうち、アルキル基、アルケニル基、アルキニル基、
アリール基、ヘテロ環基としては、一般式〔■〕のR□
、R2,R、で説明したのと同様の基が挙げら−れる。Examples of substituents among the groups represented by R1 include alkyl groups, alkenyl groups, alkynyl groups, aryl groups, heterocyclic groups, acyl groups, sulfonyl groups, oxycarbonyl groups, and carbamoyl groups. Among the substituents represented by R3, alkyl groups, alkenyl groups, alkynyl groups,
As the aryl group and heterocyclic group, R□ of the general formula [■]
, R2, R, and the same groups as explained above.
アンル基としては、アセチル、ベンゾイル等が挙ケラれ
、スルホニル基としては、メタンスルホニル、トルエン
スルホニル等が挙げられ、オキシカルボニル基としては
、エトキンカルボニル、フェノキシカルボニル等が挙げ
られ、カルバモイル基としては、メチルカルバモイル
モイル等が挙げられる。Examples of the anlu group include acetyl and benzoyl, examples of the sulfonyl group include methanesulfonyl, toluenesulfonyl, etc., examples of the oxycarbonyl group include etquin carbonyl, phenoxycarbonyl, etc., and examples of the carbamoyl group include , methylcarbamoylmoyl and the like.
R 、、R 2,R 、、R 、で形成し得る環として
は、ピペリジン、モルホリノン等の環が挙げられる。Examples of the ring that can be formed by R , , R 2,R , , R , include rings such as piperidine and morpholinone.
Rで表される基のうちアルキル基はメチル、エチル等で
あり、メチル基が好ましい。Among the groups represented by R, the alkyl group is methyl, ethyl, etc., and the methyl group is preferable.
以下に代表的具体例を示す。Typical specific examples are shown below.
l−a−1
(C)Is)zNN)l(CHzCHzO)〜,Hlー
a−2
CH2−Ph
(CH3)2N−N(CltaC)120)、HI−a
−3
(CH3)2NNH(CH2CH20)〜r acH2
cHzNHN(C)lx)2l−a−4
(CJh)tNN[((C)lzcHzo)〜.CH2
−Ph■
a−5
■
l2
C2H,
C2+’+5
CC2H,)2N
?(CH2CH20)〜3■CH2CH2NN(C2}
15)2■
a−5
(Ph
CH2)2NNH(CH2CH20)〜, ,CH2C
H2NHN(CH2Ph)2
■
a−7
S02CH3
S02CH3
(Ph−CH2)2N
?(CI{2CH■O)〜3■CH 2C}I 2NN
(CH2
Ph).
■
■
l4
CI{2
ph
(Ph CH2)2N
N(CH2CH20)〜,,CH2
ph
■
l5
COOC 2 H 6
COOC . H 5
(Ph CH2)2N
N(CH2CH20)−30C82C82N N(C
H2Ph)2
COCH.
COCH 3
■
l6
(i−C3H7)2N−N(C}l,CH,O)〜Ir
CH2CHyN N(C3H7 !)x(Ph
CH2)2NNH(CHzCH20)zcH2cH2N
[{N(CHzph) 2
■
(Pb CHx)2NNHCCH2CHxO)−3o
HVl−a
l8
(CHz=CHC[{z)2N N(CH2CHzO
)−30CH2CH2N N(CH2CH=CH2)
2CH3
(CH3)2NNH(CH2CHO)−+oH■
a −19
Vl−a
CH3
CH3
(Ph CH2)2NNH(CH2CI{2NH)〜
16F+(CH3)2NNH(CH2CHO)〜6CH
2CHNHN(CH3)2■
■
a−20
CH2−Ph
(Ph CH.)2N
N((CH2Cl42NH)〜6H〕2(CH3)2N
N(CH2CHCH20)〜6H
■
a−28
0H
(CH3)2NNH(CH2CH2S)6CH2CH2
NHN(CH3)2■
a−21
Vl−a
CH3
CQCH3
COCH 3
(CH3)2NNFI(CH,CHO)〜l 2(CH
2CHCl{20)〜6H(Ph CH2)2N
N(CH2CH2S)〜6CH2Cl{2N N(C
H2 Ph)20H
■
a−30
C2H5
CH3
VI−a−22
(Ph CH2)2N N(CH2CHC}120
)〜+o(CHzCHO)−+oH(Ph CHz)
,NNH(CHzCHCHzO)〜1480H
0H
VI−a
3l
■
a−23
CH2 Ph CH2
ph
H(OCR2CF+2)〜14N
N(CH2CH20)〜l,H
■
CH3
CH3
■
a−24
Ph CH2(OCH2CH2)−+oNN(CI{
2CH20)−10CH2 Ph(CH3)2N
N〔(CH2CH20)−+oH)z■
a−33
■
a−25
COCH s
COCH 3
(c2H6)2N
?H(CH2CH2NH)−■oH
(CH3)28 N(CH2CH20)〜32CH2
CH2N N(CH3)2■
■
a−42
COC : li 5
COC2H5
COCH 3
(Ph CH2)zN
N(cH2ch2o)〜,,CH.CH2NN(CH2
ph)2
(Ph−CH,).N−N(CH2CH2CH20)
− , 8 (CH.CHC}1.0)−1 .8■
0H
COCH 3
■
a−43
(Ph CH.)2N N(CH2CH20)〜3
3CH2−PhCH2
ph
CH2−Ph
(Ph CH2)2N
N(CH2CHpCHzO)−acHzcHzcH2N
N(Cl2
Ph)2
■
a−44
COCH,
COCH,
(CH3)2N−N(C}12CI{2CH20)−
. .CH2CH2CI{2NN(Ct{+)+
一般式
[VI)
b
■
(CH3)2NNH(CH2CH2CH20)〜8HR
l,R 2
は水素原子、
アルキル基、
アルケニル
基、
アルキニル基、
ア
リール基、
ヘテロ環基を表し、
R ,,R 2,Tで環を形成してもよい。l-a-1 (C)Is)zNN)l(CHzCHzO)~, Hl-a-2 CH2-Ph (CH3)2N-N(CltaC)120), HI-a
-3 (CH3)2NNH(CH2CH20)~racH2
cHzNHN(C)lx)2l-a-4 (CJh)tNN[((C)lzcHzo)~. CH2
-Ph■ a-5 ■ l2 C2H, C2+'+5 CC2H,)2N? (CH2CH20) ~3■CH2CH2NN(C2}
15) 2■ a-5 (Ph CH2)2NNH(CH2CH20)~, ,CH2C
H2NHN(CH2Ph)2 ■ a-7 S02CH3 S02CH3 (Ph-CH2)2N? (CI{2CH■O)〜3■CH 2C}I 2NN
(CH2 Ph). ■ ■ l4 CI{2 ph (Ph CH2)2N N(CH2CH20) ~,, CH2 ph ■ l5 COOC 2 H 6 COOC . H 5 (Ph CH2)2N N(CH2CH20)-30C82C82N N(C
H2Ph)2 COCH. COCH 3 ■ l6 (i-C3H7)2N-N(C}l, CH, O) ~ Ir
CH2CHyN N(C3H7!)x(Ph
CH2)2NNH (CHzCH20)zcH2cH2N
[{N(CHzph) 2 ■ (Pb CHx)2NNHCCH2CHxO)-3o
HVl-a l8 (CHz=CHC[{z)2N N(CH2CHzO
)-30CH2CH2N N (CH2CH=CH2)
2CH3 (CH3)2NNH(CH2CHO)-+oH■ a -19 Vl-a CH3 CH3 (Ph CH2)2NNH(CH2CI{2NH)~
16F+(CH3)2NNH(CH2CHO)~6CH
2CHNHN(CH3)2■ ■ a-20 CH2-Ph (Ph CH.)2N N((CH2Cl42NH)~6H]2(CH3)2N N(CH2CHCH20)~6H ■ a-28 0H (CH3)2NNH(CH2CH2S) 6CH2CH2
NHN(CH3)2■ a-21 Vl-a CH3 CQCH3 COCH 3 (CH3)2NNFI(CH,CHO)~l 2(CH
2CHCl{20)~6H(Ph CH2)2N
N(CH2CH2S)~6CH2Cl{2N N(C
H2 Ph) 20H ■ a-30 C2H5 CH3 VI-a-22 (Ph CH2)2N N(CH2CHC}120
)~+o(CHzCHO)-+oH(Ph CHz)
,NNH(CHzCHCHzO)~1480H 0H VI-a 3l ■ a-23 CH2 Ph CH2 ph H(OCR2CF+2)~14N N(CH2CH20)~l,H ■ CH3 CH3 ■ a-24 Ph CH2(OCH2CH2)-+oNN (C.I. {
2CH20)-10CH2 Ph(CH3)2N
N [(CH2CH20)-+oH)z ■ a-33 ■ a-25 COCH s COCH 3 (c2H6)2N? H(CH2CH2NH)-■oH (CH3)28 N(CH2CH20)~32CH2
CH2N N(CH3)2■ ■ a-42 COC: li 5 COC2H5 COCH 3 (Ph CH2)zN N(cCH2ch2o)~,,CH. CH2NN(CH2ph)2 (Ph-CH,). N-N(CH2CH2CH20)
−, 8 (CH.CHC}1.0) −1. 8 ■ 0H COCH 3 ■ a-43 (Ph CH.)2N N (CH2CH20) ~3
3CH2-PhCH2 ph CH2-Ph (Ph CH2)2N N(CH2CHpCHzO)-acHzcHzcH2N
N(Cl2 Ph)2 ■ a-44 COCH, COCH, (CH3)2N-N(C}12CI{2CH20)-
.. .. CH2CH2CI{2NN(Ct{+)+ General formula [VI) b ■ (CH3)2NNH(CH2CH2CH20) ~8HR
l and R 2 represent a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, or a heterocyclic group, and R , , R 2, and T may form a ring.
0H
■
(C4H 9 ) 2NNH(CH2C}l 2CH2
0)−2 0CH2CH 2CH2NHN(C4 H
s ) 2Tは
R
ACHz−CH−X} 又1:l. −{CH2−CH
−CH.−03y ”’Q 表Y
■
COCH3
COCH3
される基を少なく
とも一つ含む基である。0H ■ (C4H 9 ) 2NNH(CH2C}l 2CH2
0)-2 0CH2CH 2CH2NHN(C4H
s) 2T is RACHz-CH-X} and 1:l. -{CH2-CH
-CH. -03y "'Q Table Y ■ COCH3 A group containing at least one COCH3 group.
(C2H5)2N−N(CH2CH2CFI20)〜8
CH2CH2CH2N N(C2H5)2Rは水素原
子又はアルキル基を表し、
Xは0
S
又は
NH基を表し、
Yは水素原子又は
0H基を表
■
b
し、
nは2以上の整数を表す。(C2H5)2N-N(CH2CH2CFI20)~8
CH2CH2CH2N N(C2H5)2R represents a hydrogen atom or an alkyl group, X represents an 0 S or NH group, Y represents a hydrogen atom or an OH group, and n represents an integer of 2 or more.
但し、 Rか水素原 子の時、 XはS又は NH基を表すものとする。however, R or hydrogen field When I was a child, X is S or It represents an NH group.
Rl,R2で表される基のうち、
アルキル基、
ア
■
b
ルケニル基、
アルキニル基、
ア
リール基、
ヘテロ
環基としては、
一般式
〔
■
〕
のR + . R 2 . R hで説明したものと同
様の基が挙げられる。Among the groups represented by Rl and R2, the alkyl group, alkenyl group, alkynyl group, aryl group, and heterocyclic group include R + . R2. The same groups as those explained for R h can be mentioned.
R l,R 2
Tで形成し得る環としては、
ピペリジ
CH,
CH,
ン、モルホリン、キヌクリジン、ビラゾリジン等CSF
II INH(CH2CHO)−1 .CH2CHNH
CSH, 1のヘテロ環が挙げられる。Rings that can be formed with R l, R 2 T include piperidine CH, CH, morpholine, quinuclidine, virazolidine, etc.
II INH(CH2CHO)-1. CH2CHNH
Examples include heterocycles of CSH and 1.
■ b Rで表されるアルキル基としてはメチル、エチ CH3 CI{3 ル等であり、 メチル基が好ましい。■ b The alkyl group represented by R is methyl, ethyl CH3 CI{3 Le et al. Methyl group is preferred.
(CH2 =CHCH2)zN(CH2CHO)−ec
HzcHN(CHzCH=CH2)2以下に代表的具体
例を示す。(CH2 = CHCH2)zN(CH2CHO)-ec
HzcHN (CHzCH=CH2)2 Representative examples are shown below.
■
b
■
■−b
CH,
(C3}1,).N(CH2CFIO)〜6H■
b
CH+
CH.
(C=HJ2N(CHzCHO),■
(CaH+ v)xNccHxcHo)zH■
b−3
CH.
Cl3
■
b
l0
(CJs)2N(CHzCHO)〜+ *CH2CHN
(C2Ha)2CH,
CH,
(Ph CH2)zN(CHzCHO)2cH2cH
N(CH2Ph)2
■
b
■
C51(、、NH(CH2CHCI(20)〜128H
■
CH3
■
■
■
(C2H5)2N(CF]2CHCH,O)〜8HH
■
(CaH+ 7)2N(CH3CHO)120)〜14
8H
■
(CH2−CHCH2) zNccH2cHcfho)
−+ oHH
Vl−b−22
(Ph CHz)2N(CH2CHCHzO)〜3H
H
VT−b−29
CH。■ b ■ ■−b CH, (C3}1,). N(CH2CFIO)~6H■ b CH+ CH. (C=HJ2N(CHzCHO),■ (CaH+ v)xNccHxcHo)zH■ b-3 CH. Cl3 ■ b l0 (CJs)2N(CHzCHO)〜+ *CH2CHN
(C2Ha)2CH, CH, (Ph CH2)zN(CHzCHO)2cH2cH
N(CH2Ph)2 ■ b ■ C51(,,NH(CH2CHCI(20)~128H ■ CH3 ■ ■ ■ (C2H5)2N(CF]2CHCH,O)~8HH ■ (CaH+ 7)2N(CH3CHO)120)~ 14
8H ■ (CH2-CHCH2) zNccH2cHcfho)
-+ oHH Vl-b-22 (Ph CHz) 2N (CH2CHCHzO) ~ 3H
H VT-b-29 CH.
(Ct89)zN(CH3COO)−a(CHzCHC
HzO)−1oFIH
VI−b−30
Vl−b−31
CH。(Ct89)zN(CH3COO)-a(CHzCHC
HzO)-1oFIH VI-b-30 Vl-b-31 CH.
(C12
CHCH2>tNccH2cHcH,o)、−1,(C
)12c)10)−、oHH
■−b−32
CH3
CmH+tNHCCHtCHO’)−3−CCHxCH
CHzO)−zaHH
vr−b−33
Vl−b−34
■
b
■
(C41(り2N(CH2C)12NH)〜14’1■
(CH,=CHC)12)2N(CH2C)12NH)
〜2゜HしHl
■
■
Call□NH(CH2C82CH)〜+6H■
Vl−b−45
■
■
■
(Cx1(y)2N(C4C)lzs)〜5cH2cF
lzN(C3H+)iv+−b
C,H%
C,H。(C12 CHCH2>tNccH2cHcH,o), -1, (C
)12c)10)-,oHH ■-b-32 CH3 CmH+tNHCCHtCHO')-3-CCHxCH
CHzO)-zaHH vr-b-33 Vl-b-34 ■ b ■ (C41(ri2N(CH2C)12NH)~14'1■ (CH,=CHC)12)2N(CH2C)12NH)
~2゜H Hl ■ ■ Call□NH (CH2C82CH) ~+6H■ Vl-b-45 ■ ■ ■ (Cx1(y)2N(C4C)lzs) ~5cH2cF
lzN(C3H+)iv+-b C,H% C,H.
■
CH2−C)1cH2N(CH3CO,S)〜1゜CH
2C82C)12cl(−CH2(C)1.CH=CI
(C1(2)2N(CH2CH2■
■−b
C,I(、、N)1(C)12cI(2S)〜l□CH
2CH2NHC,H,。■ CH2-C)1cH2N(CH3CO,S)~1°CH
2C82C)12cl(-CH2(C)1.CH=CI
(C1(2)2N(CH2CH2■■-b C,I(,,N)1(C)12cI(2S)~l□CH
2CH2NHC,H,.
v+−b
VI−b−57
■−b−51
■
(C4H,)2N(CH2C82C)1,0)〜、HV
l−b−59
■
(CH2−CI(CHz)zN(C)lzcHzcHz
o)〜1゜Ht−b
C,H。v+-b VI-b-57 ■-b-51 ■ (C4H,)2N(CH2C82C)1,0)~, HV
l-b-59 ■ (CH2-CI(CHz)zN(C)lzcHzcHz
o) ~1°Ht-b C,H.
CI(;CC1(、N(CI(2CO,CH,O)〜1
4H■−b−61
■
C3H。CI(;CC1(,N(CI(2CO,CH,O)~1
4H ■-b-61 ■ C3H.
■
CH=CC)12N1((CI(2CH2S)−2゜C
H2CH2NHCH2C=CHC0,= CHCH,N
(CH,CH2C82C)〜+ *(C)IxCHCH
*O)〜1゜HH
VT−b−62
C,H,、N1((CHICI(、CH20)〜12H
Vl−b−63
般式(Vl) −c
■
■
Vl−b−66
Vl−b−67
■
しt13
(C2H8)2N(CH,CH2CH,0)−2oCH
2CH2CH,N(C2H6)2R+ 、 R2は水素
原子、アルキル基、アルケニル基、アルキニル基、アリ
ール基、ヘテロ環基を表し、R1,R2,Gで環を形成
してもよい。■ CH=CC)12N1((CI(2CH2S)-2°C
H2CH2NHCH2C=CHC0,= CHCH,N
(CH, CH2C82C) ~+ *(C)IxCHCH
*O)~1゜HH VT-b-62 C,H,,N1((CHICI(,CH20)~12H
Vl-b-63 General formula (Vl) -c ■ ■ Vl-b-66 Vl-b-67 ■ t13 (C2H8)2N(CH,CH2CH,0)-2oCH
2CH2CH,N(C2H6)2R+, R2 represents a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, or a heterocyclic group, and R1, R2, and G may form a ring.
Gは−(CI(2CH20)E−で表される基を少なく
とも一つ含み、かつ疎水性置換基定数π値か−0,5〜
−1,0の置換基を少なくとも二つ含むか、又はπ値か
=1,0より小の置換基を少なくとも一つ含むものとす
る。nは2以上の整数を表す。G contains at least one group represented by -(CI(2CH20)E-) and has a hydrophobic substituent constant π value of -0,5 to
It shall contain at least two substituents of −1,0 or at least one substituent whose π value is smaller than 1,0. n represents an integer of 2 or more.
R、、R2で表される基のうち、アルキル、アルケニル
、アルキニル、アリール、ヘテロ環の6基としては、一
般式〔■〕のRl、R2+Rhで説明したのと同様の基
が挙げられる。Among the groups represented by R and R2, the six groups of alkyl, alkenyl, alkynyl, aryl, and heterocycle include the same groups as explained for Rl and R2+Rh in the general formula [■].
R、、R2,Gで形成し得る環としては、例えはピペリ
ジン、キヌクリジン、モルホリン等の環が挙げられる。Examples of the ring that can be formed by R, , R2, and G include rings such as piperidine, quinuclidine, and morpholine.
疎水性置換基定数πについては、薬物の構造活性化相関
(南江堂)、79〜103頁(昭和54年)に記載され
ている。The hydrophobic substituent constant π is described in Structure-Activation Relationship of Drugs (Nankodo), pp. 79-103 (1978).
π値が−0,5〜−1,0の置換基としては、例えば−
1,0より小の置換基としては、例えば−coNH2゜
C0NHOH,””C0NHCH3,−NHffi、−
NHCONHz、 NHC5NH2゜NHSO,CF
I3.−N”(CI(3)3.−Oe、 −0CONH
2,−3O3”。Examples of substituents with a π value of -0,5 to -1,0 include -
Examples of substituents smaller than 1,0 include -coNH2゜C0NHOH, ""C0NHCH3, -NHffi, -
NHCONHz, NHC5NH2゜NHSO, CF
I3. -N"(CI(3)3.-Oe, -0CONH
2,-3O3”.
−5OzNL、 −5OCI(3,5OzCHx、−C
OO6等の基が挙げられる。-5OzNL, -5OCI (3,5OzCHx, -C
Examples include groups such as OO6.
以下に代表的具体例を示す。Typical specific examples are shown below.
Vl−c〜1
(i C5H7)zN(CHzCFIzO)sctl
*cONH*Vl−c〜2
(i−C,H,)、N(CH2CH2,0)3CH,C
OONaI−c−3
CCxHs)xNccfh(JbO)scONHz1−
c−4
(HOCHzCJCHz)zN(CH2CH2O)s)
II−c−5
■
■
T−c
■
■
C)12=CHC82NH(CH2CH20)〜6CH
,C00K(CI(−iiCCH2)2N(C)12C
H20)〜、C)12CONI(2C,H7
CH2= CHCI(2N(CH2CH20)〜、 C
H、C0NHCH。Vl-c~1 (i C5H7)zN(CHzCFIzO)sctl
*cONH*Vl-c~2 (i-C,H,), N(CH2CH2,0)3CH,C
OONaI-c-3 CCxHs)xNccfh(JbO)scONHz1-
c-4 (HOCHzCJCHz)zN(CH2CH2O)s)
II-c-5 ■ ■ T-c ■ ■ C) 12=CHC82NH (CH2CH20) ~ 6CH
,C00K(CI(-iiCCH2)2N(C)12C
H20)~, C) 12CONI(2C, H7 CH2= CHCI(2N(CH2CH20)~, C
H, C0NHCH.
CFI。C.F.I.
(CHz −COCH2)2N(CH2CH20)−6
CH,CONH2■
■
■
■
I−c
■
■
■
■
(HOC82CH2)2N(CH2CH20)〜l 4
CH2CH2N(CH2CH,0H)2■
■
■
■
■
Vl−c−35
■
■
本発明を適用した高コントラストな画像を得ることがで
きるハロゲン化銀写真感光材料中には、上記一般式〔A
〕で表されるヒドラジン化合物か少なくとも1種及び〔
■〕〜CVI’lで表される造核促進化合物の少なくと
も1種が含有されるが、該写真感光材料に含まれる一般
式(A)及び〔I〕〜CVI)の化合物の量は、写真感
光材料中に含有されるハロゲン化銀1モル当たり5 X
10−’モル〜5XIO−’モルであることが好まし
い。(CHz -COCH2)2N(CH2CH20)-6
CH, CONH2 ■ ■ ■ ■ I-c ■ ■ ■ ■ (HOC82CH2) 2N (CH2CH20) ~ l 4
CH2CH2N(CH2CH,0H)2 ■ ■ ■ ■ ■ Vl-c-35 ■ ■ Silver halide photographic materials capable of obtaining high-contrast images to which the present invention is applied include the above general formula [A
] and at least one hydrazine compound represented by [
(2) At least one nucleation-promoting compound represented by ~CVI'l is contained, but the amount of the compound of general formula (A) and [I] ~CVI) contained in the photographic light-sensitive material is 5X per mole of silver halide contained in the light-sensitive material
Preferably, it is between 10-' mol and 5XIO-' mol.
特に5 X 10−’モル〜I X 10−”モルの範
囲とすることが好ましい。In particular, it is preferably in the range of 5 x 10-' moles to I x 10-' moles.
本発明のハロゲン化銀写真感光材料は、少なくとも一層
のハロゲン化銀乳剤層を有する。すなわちハロゲン化銀
乳剤層は、支持体の片面に少なくとも一層設けられてい
ることもあるし、支持体の両面に少なくとも一層設けら
れていることもある。The silver halide photographic material of the present invention has at least one silver halide emulsion layer. That is, at least one silver halide emulsion layer may be provided on one side of the support, or at least one silver halide emulsion layer may be provided on both sides of the support.
そして、このハロゲン化銀乳剤は支持体上に直接塗設さ
れるか、あるいは他の層例えばハロゲン化銀乳剤を含ま
ない親水性コロイド層を介して塗設されることができ、
更にハロゲン化銀乳剤層の上には、保護層としての親水
性コロイド層を塗設してもよい。又、ハロゲン化銀乳剤
層は、異なる感度、例えは高感度及び低感度の各ハロゲ
ン化銀乳剤層に分けて塗設してもよい。この場合、各ハ
ロゲン化銀乳剤層の間に、中間層を設けてもよい。Then, this silver halide emulsion can be coated directly on the support, or it can be coated via another layer such as a hydrophilic colloid layer that does not contain the silver halide emulsion.
Furthermore, a hydrophilic colloid layer as a protective layer may be coated on the silver halide emulsion layer. Further, the silver halide emulsion layer may be coated separately into silver halide emulsion layers having different sensitivities, for example, high-sensitivity and low-sensitivity silver halide emulsion layers. In this case, an intermediate layer may be provided between each silver halide emulsion layer.
すなわち必要に応じて親水性コロイドから成る中間層を
設けてもよい。又、ハロゲン化銀乳剤層と保護層との間
に、中間層、保護層、アンチハレーンヨン層、バッキン
グ層などの非感光性親水性コロイド層を設けてもよい。That is, an intermediate layer made of hydrophilic colloid may be provided if necessary. Further, a non-photosensitive hydrophilic colloid layer such as an intermediate layer, a protective layer, an antihalation layer, or a backing layer may be provided between the silver halide emulsion layer and the protective layer.
般式(A)、CI)〜CVI)で表される化合物は本発
明のハロゲン化銀写真感光材料中のハロゲン化銀乳剤層
または該ハロゲン化銀乳剤層に隣接する親水性コロイド
層に含有させる。The compounds represented by formulas (A), CI) to CVI) are contained in the silver halide emulsion layer or the hydrophilic colloid layer adjacent to the silver halide emulsion layer in the silver halide photographic light-sensitive material of the present invention. .
次に本発明のハロゲン化銀写真感光材料に用いるハロゲ
ン化銀について説明する。ハロゲン化銀としては、4モ
ル%以下の沃化銀、好ましくは3モル%以下の沃化銀を
含む塩沃臭化銀、もしくは沃臭化銀である。このハロゲ
ン化銀の粒子の平均径は0.05〜0.5μmの範囲の
ものが好ましく用いられるが、なかでも0.lO〜0.
40p mのものが好適である。Next, the silver halide used in the silver halide photographic material of the present invention will be explained. The silver halide is silver chloroiodobromide or silver iodobromide containing 4 mol % or less of silver iodide, preferably 3 mol % or less of silver iodide. The average diameter of the silver halide particles is preferably in the range of 0.05 to 0.5 μm, particularly 0.05 to 0.5 μm. lO~0.
40pm is preferred.
本発明で用いるハロゲン化銀粒子の粒径分布は任意であ
るが、以下定義する単分散度の値が1〜20%のものが
好ましく、更に好ましくは5〜15%の範囲となるよう
に調整する。Although the particle size distribution of the silver halide grains used in the present invention is arbitrary, it is preferably adjusted so that the monodispersity value defined below is in the range of 1 to 20%, and more preferably in the range of 5 to 15%. do.
ここで単分散度は、粒径の標準偏差を平均粒径で割った
値(変動係数)を100倍した数値(%)として定義さ
れるものである。なおハロゲン化銀粒子の粒径は、便宜
上、立方晶粒子の場合は稜長で表し、その他の粒子(8
面体、■4面体等)は、投影面積の平方根で算出する。Here, the monodispersity is defined as a value (%) obtained by multiplying by 100 the value obtained by dividing the standard deviation of particle diameter by the average particle diameter (coefficient of variation). For convenience, the grain size of silver halide grains is expressed by the edge length in the case of cubic grains, and is expressed by the edge length for other grains (8
(Hedron, Tetrahedron, etc.) are calculated by the square root of the projected area.
本発明を実施する場合、例えばハロゲン化銀の粒子とし
て、その構造が少なくとも2層の多層積層構造を有する
タイプのものを用いることかでき、例えばコア部に沃臭
化銀、シェル部が臭化銀である沃臭化銀粒子から成るも
のを用いることができる。このとき、沃素を任意の層に
5モル%以内で含有させることができる。When carrying out the present invention, for example, silver halide grains having a multilayer structure of at least two layers can be used, for example, silver iodobromide in the core and bromide in the shell. Those consisting of silver iodobromide grains, which are silver, can be used. At this time, iodine can be contained in any layer within 5 mol%.
本発明のハロゲン化銀乳剤に用いられるハロゲン化銀粒
子は、粒子を形成する過程及び/又は成長させる過程で
、カドミウム塩、亜鉛塩、鉛塩、タリウム塩、イリジウ
ム塩(#塩を含む)、ロジウム塩(錯塩を含む)及び鉄
塩(錯塩を含む)から選ばれる少なくとも1種を用いて
金属イオンを添加し、粒子内部に及び/又は粒子表面に
これらの金属元素を含有させることができ、又、適当な
還元的雰囲気におくことにより、粒子内部及び/又は粒
子表面に還元増感核を付与できる。The silver halide grains used in the silver halide emulsion of the present invention are formed by cadmium salt, zinc salt, lead salt, thallium salt, iridium salt (including # salt), Metal ions can be added using at least one selected from rhodium salts (including complex salts) and iron salts (including complex salts) to contain these metal elements inside the particles and/or on the surface of the particles, Further, by placing the particles in an appropriate reducing atmosphere, reduction sensitizing nuclei can be provided inside the particles and/or on the particle surfaces.
更Iこ又、ハロゲン化銀は種々の化学増感剤によって増
感することができる。その増感剤として、例えば、活性
ゼラチン、硫黄増感剤(チオ硫酸ソダ、アリルチオカル
バミド、チオ尿素、アリルイソチアシネート等)、セレ
ン増感剤(N、N−ジメチルセレノ尿素、セレノ尿素等
)、還元増感剤(トリエチレンテトラミン、塩化銀1錫
等)、例えばカリウムクロロオーライト、カリウムオー
リチオシアネート、カリウムクロロオーレート、2−オ
ーロスルホベンゾチアゾールメチルクロライド、アンモ
ニウムクロロパラデート、カリウムクロロプラチ洋−ト
、ナトリウムクロロバラダイト等で代表される各種貴金
属増感剤等をそれぞれ単独で、あるいは2種以上併用し
て用いることができる。Additionally, silver halide can be sensitized by various chemical sensitizers. Examples of the sensitizer include activated gelatin, sulfur sensitizers (sodium thiosulfate, allylthiocarbamide, thiourea, allyl isothiacinate, etc.), selenium sensitizers (N,N-dimethylselenourea, selenourea, etc.) ), reduction sensitizers (triethylenetetramine, tin silver chloride, etc.), such as potassium chlorooleite, potassium aurithiocyanate, potassium chlorooleate, 2-ourosulfobenzothiazole methyl chloride, ammonium chloroparadate, potassium chloroplatinate Various noble metal sensitizers typified by sodium chloride, sodium chlorovaladite, etc. can be used alone or in combination of two or more.
なお金増感剤を使用する場合は助剤的にロダンアンモン
を使用することもできる。When using a metal sensitizer, rhodanammonium can also be used as an auxiliary agent.
本発明に用いるハロゲン化銀粒子は、内部の感度より表
面感度の高い粒子、謂ゆるネガ画像を与えるハロゲン化
銀粒子に好ましく適用することができるので上記化学増
感剤で処理することにより性能を高めることができる。The silver halide grains used in the present invention can be preferably applied to grains whose surface sensitivity is higher than their internal sensitivity, so-called silver halide grains that give negative images. can be increased.
又、本発明に用いられるハロゲン化銀乳剤は、メルカプ
ト類(l−フェニル−5−メルカプトテトラゾール、2
−メルカプトベンツチアゾール)、ベンゾトリアゾール
類(5−ブロムベンゾトリアゾール5−メチルベンゾト
リアゾール
ゾール類(6−ニドロペンツイミダゾール)などを用い
て安定化又はカブリ抑制を行うことができる。Further, the silver halide emulsion used in the present invention contains mercapto compounds (l-phenyl-5-mercaptotetrazole, 2
-Mercaptobenzthiazole), benzotriazoles (5-bromobenzotriazole 5-methylbenzotriazole (6-nidropenzimidazole), etc.) can be used to stabilize or suppress fog.
感光性ハロゲン化銀乳剤層又はその隣接層には、感度上
昇、コントラスト上昇または現像促進の目的でリサーチ
・ディスクロージャー( ResearchDiscl
ousure) 17463号のXXI項B−D項に記
載されている化合物を添加することができる。The photosensitive silver halide emulsion layer or its adjacent layer may contain a Research Disclosure (Research Disclosure) for the purpose of increasing sensitivity, increasing contrast, or promoting development.
Compounds described in Section XXI B-D of No. 17463 can be added.
又、下記の一般式CP)で表される化合物を添加するこ
とか好ましい。Further, it is preferable to add a compound represented by the following general formula CP).
一般式〔P〕
R1−0イCH2CH20坩H
〔式中R1は水素原子、あるいは無置換又は置換基をも
つ芳香族環を表し、nはlO〜200までの整数を表す
。〕
まず、一般式(P)で表される化合物より好ましい具体
例をあげる。分子量は1500以上のものか好ましいが
、これらに限定されるものではない。General formula [P] R1-0 CH2CH20H [In the formula, R1 represents a hydrogen atom or an unsubstituted or substituted aromatic ring, and n represents an integer from 1O to 200. ] First, specific examples more preferable than the compound represented by the general formula (P) will be given. The molecular weight is preferably 1500 or more, but is not limited thereto.
P l 80(CH,CHzC)nH
n=lOP 2 HO(CHxCLO
)nH n−30P 3 HO(
CHzCH20)n)l n□50P 4
HO(CHzC)120)nH
n=70P − 5 HO(CH2Cl.O)
nl( n=150P 6 HO(
CHzCH20)nl( n=200これらの
化合物は、市販されており容易に入手することができる
。これらの化合物はハロゲン化銀1モルに対し0,Ol
〜4.0モル添加するのが好ましく、0.02〜2モル
がより好ましい。又、乳剤層中に含有させることが好ま
しい。又、nの値が異なる2種以上の化合物を含んでも
構わない。P l 80(CH,CHzC)nH
n=lOP2HO(CHxCLO
) nH n-30P 3 HO (
HzCH20)n)l n□50P 4
HO(CHzC)120)nH
n=70P − 5 HO (CH2Cl.O)
nl( n=150P 6 HO(
CHzCH20) nl (n=200 These compounds are commercially available and can be easily obtained.
It is preferable to add up to 4.0 mol, more preferably 0.02 to 2 mol. It is also preferable to include it in the emulsion layer. Further, two or more types of compounds having different values of n may be included.
本発明に用いられるハロゲン化銀乳剤には、増感色素、
可塑剤、帯電防止剤、界面活性剤、硬膜剤などを加える
こともできる。本発明に係る一般式(A)、〔I)〜〔
■〕の化合物を親水性コロイド層に添加する場合、該親
水性コロイド層のバインダーとしてはゼラチンが好適で
あるか、ゼラチン以外の親水性コロイドも用いることが
できる。The silver halide emulsion used in the present invention includes a sensitizing dye,
Plasticizers, antistatic agents, surfactants, hardeners, etc. can also be added. General formula (A), [I) to [
When the compound (2) is added to a hydrophilic colloid layer, gelatin is suitable as the binder for the hydrophilic colloid layer, or hydrophilic colloids other than gelatin can also be used.
これらの親水性バインダーは支持体の両面にそれぞれ1
0g/m2以下で塗設することか好ましい。These hydrophilic binders are coated on each side of the support.
It is preferable to apply the coating at 0 g/m2 or less.
本発明の実施に際して用い得る支持体としては、例えば
バライタ紙、ポリエチレン被覆紙、ポリプロピレン合成
紙、ガラス板、セルロースアセテート、セルロースナイ
トレート、例えはポリエチレンテレフタレートなどのポ
リエステルフィルムを挙けることができる。これらの支
持体は、それぞれハロゲン化銀写真感光材料の使用目的
に応じて適宜選択される。Supports that can be used in the practice of the present invention include, for example, baryta paper, polyethylene-coated paper, polypropylene synthetic paper, glass plates, cellulose acetate, cellulose nitrate, and polyester films such as polyethylene terephthalate. These supports are appropriately selected depending on the intended use of the silver halide photographic material.
本発明のハロゲン化銀写真感光材料を現像処理するには
、例えば以下の現像主薬が用いられる。For developing the silver halide photographic material of the present invention, the following developing agents are used, for example.
HO−(CH= CI()n” O)lを現像主薬の代
表的なものとしては、ハイドロキノンがあり、その他に
カテコール、ピロガロールなどがある。Typical developing agents for HO-(CH=CI()n''O)l include hydroquinone, and others include catechol and pyrogallol.
又、HO(CH−CH)n NH2型現像現像剤ては
、オルト及びパラのアミノフェノール又はアミノピラゾ
ロンが代表的なもので、N−メチル−p−アミノフェノ
ール、N−β−ヒドロキンエチル−p−アミンフェノー
ル、p−ヒドロキンフェニルアミノ酢酸、2−アミノナ
フトール等かある。In addition, typical examples of HO(CH-CH)n NH2 type developers include ortho and para aminophenol or aminopyrazolone, N-methyl-p-aminophenol, N-β-hydroquinethyl- Examples include p-aminephenol, p-hydroquinphenylaminoacetic acid, and 2-aminonaphthol.
ペテロ環型現像剤としては、1−フェニル−3−ピラゾ
リドン、■−フェニルー44−ジメチルー3−ピラゾリ
ドン、■−フェニルー4−メチルー4−ヒドロキンメチ
ル−3−ピラゾリドン、l−フェニル−4−メチル−4
−ヒドロキンメチル−3−ピラゾリドンのような3−ピ
ラゾリドン類等を挙げることができる。Examples of petrocyclic type developers include 1-phenyl-3-pyrazolidone, ■-phenyl-44-dimethyl-3-pyrazolidone, ■-phenyl-4-methyl-4-hydroquinemethyl-3-pyrazolidone, and l-phenyl-4-methyl-3-pyrazolidone. 4
Examples include 3-pyrazolidones such as -hydroquinemethyl-3-pyrazolidone.
その他、T、H,ジェームス著ザ・セオリイ・オブ・ザ
・ホトグラフィック・プロセス第4版(The The
ory of the Pbotographic P
rocessFourth Edition)第291
〜334頁及びジャーナル・オブ・ザ・アメリカン・ケ
ミカル・ンサエティ(Journal of the
American Chemical 5ociety
)第73巻、第3.100頁(1951)に記載されて
いる如き現像剤か本発明に有効に使用し得るものである
。Other books include The Theory of the Photographic Process, 4th edition, by T. H. James.
ory of the Pbotographic P
rocessFourth Edition) No. 291
~334 pages and Journal of the American Chemical Society.
American Chemical 5ociety
), Vol. 73, p. 3.100 (1951), can be effectively used in the present invention.
これらの現像剤は単独で使用しても2種以上組み合わせ
てもよいが、2種以上を組み合わせて用いる方が好まし
い。These developers may be used alone or in combination of two or more types, but it is preferable to use two or more types in combination.
又、本発明の感光材料の現像に使用する現像液には保恒
剤として、例えば亜硫酸ソーダ、亜硫酸カリ等の亜硫酸
塩を用いても、本発明の効果が損なわれることはない。Furthermore, even if a sulfite salt such as sodium sulfite or potassium sulfite is used as a preservative in the developer used for developing the photosensitive material of the invention, the effects of the invention will not be impaired.
又、保恒剤としてヒドロキンメチルン、ヒドラジド化合
物を用いてもよい。Additionally, hydroquinemethylane or hydrazide compounds may be used as preservatives.
その他一般白黒現像液で用いられるような苛性アルカリ
、炭酸アルカリ又はアミンなとによるpHの調整とバッ
ファー機能をもたせることができる。In addition, pH adjustment and a buffer function can be provided using caustic alkali, carbonate alkali, or amine, which are used in general black and white developers.
本発明に用いられる現像液はpF111未渦のものが使
用できるのが特徴である。又現像液にはブロムカリなど
無機現像抑制剤及び5−メチルベンゾトリアゾール、5
−メチルベンツイミダゾール、5−ニトロインダゾール
、アデニン、グアニン、■−フェニルー5−メルカプト
テトラゾールなどの有機現像抑制剤、エチレンジアミン
四酢酸等の金属イオン捕捉剤、メタノール、エタノール
、ベンジルアルコール、ポリアルキレンオキシド等の現
像促進剤、アルキルアリールスルホン酸ナトリウム、天
然のサポニン、糖類または前記化合物のアルキルエステ
ル物等の界面活性剤、グルタルアルデヒド、ホルマリン
、グリオキザール等の硬膜剤、硫酸ナトリウム等のイオ
ン強度R整剤等の添加を行うことは任意である。The developing solution used in the present invention is characterized in that a pF111 non-vortexed developer can be used. In addition, the developer contains an inorganic development inhibitor such as brompotash, 5-methylbenzotriazole, 5
-Organic development inhibitors such as methylbenzimidazole, 5-nitroindazole, adenine, guanine, ■-phenyl-5-mercaptotetrazole, metal ion scavengers such as ethylenediaminetetraacetic acid, methanol, ethanol, benzyl alcohol, polyalkylene oxide, etc. Development accelerators, sodium alkylarylsulfonates, natural saponins, surfactants such as sugars or alkyl esters of the above compounds, hardening agents such as glutaraldehyde, formalin, glyoxal, ionic strength R adjusters such as sodium sulfate, etc. The addition of is optional.
本発明において使用される現像液には、有機溶媒として
ジェタノールアミンやトリエタノールアミン等のアルカ
ノールアミン類やジエチレングリコ−4,1−’)エチ
レングリコール等のクリコール類、又、シュチルアミノ
−1,2−プロパンジオール、ブチルアミツブロバノー
ル等のアルキルアミノアルコール類を含有させてもよい
。The developer used in the present invention includes organic solvents such as alkanolamines such as jetanolamine and triethanolamine, glycols such as diethylene glycol-4,1-') ethylene glycol, and stylamino-1,2- Alkylamino alcohols such as propanediol and butylamitubrobanol may also be included.
以下に本発明の具体的実施例を述へるか、本発明の実施
の態様はこれらに限定されない。Specific examples of the present invention will be described below, but the embodiments of the present invention are not limited thereto.
実施例1
(ハロゲン化銀乳剤Aの調製)
同時混合法を用いて沃臭化銀乳剤(銀1モル当たり沃化
銀2モル%)を調製した。この混合時にX21rC4,
を銀1モル当たり8X 10−’モル添加した。Example 1 (Preparation of Silver Halide Emulsion A) A silver iodobromide emulsion (2 mol % of silver iodide per 1 mol of silver) was prepared using a simultaneous mixing method. During this mixing, X21rC4,
was added at 8X 10-' moles per mole of silver.
得られた乳剤は、平均粒径0.20μmの立方体単分散
粒子(変動係数9.5%)からなる乳剤であった。The obtained emulsion was an emulsion consisting of cubic monodisperse grains (coefficient of variation 9.5%) with an average grain size of 0.20 μm.
この乳剤に銀1モル当I;す6.5m12の1%沃化カ
リウム水溶液を添加した後、変成ゼラチン(特願平]−
180787号の例示化合物G−8)を加え、特願平1
−1890787号の実施例1と同様の方法で水洗、脱
塩した。脱塩後の40°CでのpAgは8,0であった
。After adding 6.5 m12 of a 1% potassium iodide aqueous solution per mole of silver to this emulsion, modified gelatin (patent application) -
By adding exemplified compound G-8) of No. 180787,
It was washed with water and desalted in the same manner as in Example 1 of No.-1890787. The pAg at 40°C after desalting was 8.0.
更に再分散時に抗菌剤として下記化合物〔A〕、〔B〕
、〔C〕の混合物を添加した。Furthermore, the following compounds [A] and [B] can be used as antibacterial agents during redispersion.
, [C] was added.
CA3 (B〕 (C)キング層をゼラ
チン量が2.4g/m2になるように塗設し、更にその
上に下記処方(4)のバンキング保護層をゼラチン量が
1.Og/m2になるように塗設して試料No、t〜3
0を得た。CA3 (B) (C) Coat a king layer with a gelatin amount of 2.4 g/m2, and then apply a banking protective layer with the following formulation (4) on top of it with a gelatin amount of 1.0 g/m2. Sample No. t~3
I got 0.
処方(1)(ハロゲン化銀乳剤層組成)ゼラチン
2.0g/m2ハロゲン化銀乳剤
A(銀量) 3.2g/m2増感色素:
(ハロゲン化銀写真感光材料の作製)
両面に厚さ0.1μmの下塗層(特開昭59−1994
1号の実施例1参照)を施した厚さ100μ町のポリエ
チレンテレフタートフイルムの一方の下塗層上に、下記
処方(1)のハロゲン化銀乳剤層をゼラチン量が2.0
g/m2、銀量が3.2g/m2になるように塗設し、
更にその上に下記処方(2)の乳剤保護層をゼラチン量
が1.0g/m2になるように塗設した。又反対側のも
う一方の下塗層上には下記処方(3)のバラ安定剤:4
−メチル−6−ヒドロキシ
1.3.3a、7−チトラザインデン
カブリ防止剤:アデニン
界面活性剤:サポニン
30mg/m”
10 mg/m!
0.1g/m2
界面活性剤、5−1
8、Qmg/ff12
CI(zcQo(Cth)set(3
Na03S CHCOO(CHz)zCH(COx)
z本発明に係るヒドラノン誘導体
本発明に係る造核促進化合物
ラテックスポリマー:
30+ng/m”
100+ng/m”
1g/m”
マット剤:平均粒径3.5μmのソリカ硬膜剤: ホル
マリン
界面活性剤:S−3
NaO3S−CI(COOCH2(CF2)、HCI(
2COOC)I2(CF2)sH3mg/m”
30mg/m2
10mg/m2
処方(3)(バンキング層組成)
m : n −50: 50
ポリ工チレングリコール分子量4000 0.1g/m
2硬膜剤:H−1
CH2So 、 H
処方(2)(乳剤保護層組成)
ゼラチン
0.9g/m2
界面活性剤:S
So、Na
O3Na
ゼラチン
2.4g/m″
界面活性剤:サポニン
0.1g/+n”
:S−1
6111g/II+”
処方(4)(バンキング保護層組成)
ゼラチン
1g/l112
マット剤:平均粒径3.0〜5.0μmのポリメチルメ
タクリート 15+ng/m2界面活性剤: S −
210mg/m2硬膜剤:グリオキザール
25mg/m2” :H135mg/+a2
得られた試料について、下記の方法による網点品質試験
を行った。Prescription (1) (Silver halide emulsion layer composition) Gelatin
2.0 g/m2 Silver halide emulsion A (silver amount) 3.2 g/m2 Sensitizing dye: (Preparation of silver halide photographic light-sensitive material) Undercoat layer with a thickness of 0.1 μm on both sides (Unexamined Japanese Patent Application Publication No. 1983-1982) 1994
A silver halide emulsion layer having the following formulation (1) with a gelatin amount of 2.0 was applied on one undercoat layer of a polyethylene tereftate film having a thickness of 100 μm (see Example 1 of No. 1).
g/m2, coating so that the silver amount is 3.2 g/m2,
Furthermore, an emulsion protective layer having the following formulation (2) was coated thereon so that the amount of gelatin was 1.0 g/m2. Also, on the other undercoat layer on the opposite side, apply a bulk stabilizer of the following formulation (3): 4
-Methyl-6-hydroxy 1.3.3a, 7-chitrazaindene Antifoggant: Adenine Surfactant: Saponin 30 mg/m" 10 mg/m! 0.1 g/m2 Surfactant, 5-1 8, Qmg/ff12 CI(zcQo(Cth)set(3 Na03S CHCOO(CHz)zCH(COx)
zHydranon derivative according to the present invention Nucleation promoting compound according to the present invention Latex polymer: 30+ng/m"100+ng/m"1g/m" Matting agent: Solica hardener with an average particle size of 3.5 μm: Formalin surfactant: S-3 NaO3S-CI (COOCH2(CF2), HCI(
2COOC)I2(CF2)sH3mg/m" 30mg/m2 10mg/m2 Prescription (3) (Banking layer composition) m: n -50: 50 Polyethylene glycol molecular weight 4000 0.1g/m
2 Hardener: H-1 CH2So, H Prescription (2) (Emulsion protective layer composition) Gelatin 0.9 g/m2 Surfactant: S So, Na O3Na Gelatin 2.4 g/m'' Surfactant: Saponin 0. 1g/+n": S-1 6111g/II+" Prescription (4) (Banking protective layer composition) Gelatin 1g/l 112 Matting agent: Polymethyl methacrylate with average particle size of 3.0 to 5.0 μm 15+ng/m2 Surfactant : S-
210mg/m2 Hardener: Glyoxal
25mg/m2": H135mg/+a2 The resulting sample was subjected to a halftone quality test using the method described below.
(網点品質試験方法)
ステップウェッジに網点面積50%の返し網スクリーン
(150線/インチ)を一部付して、これに試料を密着
させてキセノン光源で5秒間露光を与え、この試料を下
記現像液、下記定着液を投入した迅速処理用自動現像機
にて下記の条件で現像処理を行い、試料の網点品質を1
00倍のルーペで観察し、網点品質の高いものを「5」
ランクとし、以下「4」、「3」、「2」、「1」と、
そのランクを順次下げて評価するものとした。尚、ラン
ク「1」及び「2」は実用上好ましくないレベルである
。(Half dot quality test method) A part of the step wedge is attached with a halftone screen (150 lines/inch) with a halftone dot area of 50%, and the sample is placed in close contact with this and exposed to a xenon light source for 5 seconds. The sample was developed under the following conditions using an automatic processing machine for rapid processing using the following developer and fixer, and the halftone quality of the sample was reduced to 1.
Observe with a 00x magnifying glass and rate the one with high halftone quality as "5"
Ranked below as "4", "3", "2", "1",
The ranking was lowered in order for evaluation. Incidentally, ranks "1" and "2" are levels that are practically unfavorable.
又、網点中のカブリも同様に評価し、網点中に全く黒ピ
ンの発生していないものを最高ランク「5」とし、網点
中に発生する黒ビンの発生度に応じてランク「4」、「
3」、「2」、「1」とそのランクを順次下げて評価す
るものとした。尚、ランクrl+及び「2」では黒ピン
も大きく実用上好ましくないレベルである。Fog in the halftone dots is evaluated in the same way, and the highest rank is "5" when no black pins occur in the halftone dots, and the rank is "5" depending on the degree of occurrence of black pins in the halftone dots. 4", "
The evaluation was made in descending order of rank: "3", "2", and "1". Incidentally, in ranks rl+ and "2", the black pins are also large and are at a practically unfavorable level.
現像液処方 現像液1
現像液2エチレンジアミン四酢酸ナトリウム塩
1g 1g亜硫酸ナトリウム
60g 60g燐酸三ナトリウム(1
2水塩)75g
硼酸 −40gハ
イドロキノン 22.5
g 35g水酸化ナトリウム
8g 8g臭化ナトリウム
3g 3g5−メチルベンゾ
トリアゾール 0.25g 0.2g
1−フェニル−5−メルカプトテトラゾール 0.
08g 0.08g1−フェニル−4−メチル−4−
ヒドロキシメチル −0,2g3−ビラゾリドン
メトール 0.25g
フェネチルピコリニウムブロマイド −2,5
g水を加えて 112
12水酸化ナトリウムにてpHを調整
pH−10,8pH=lO,8定着液処方
(組成A)
チオ硫酸アンモニウムC72,5w/v%水溶汐)
240m12亜硫酸ナトリウム
17g酢酸ナトリウム・3水塩
6.5μm1m
6gクエン酸ナトリウム・2水塩
2g(組成り)
純水(イオン交換水)17mΩ
硫酸(50%W/Vの水溶液)
4.7g硫酸アルミニウム
26.5g(AI220s換算含量が8.1w/v%の
水溶液)定着液の使用時Jこ水500mff中に上記組
成A1組成りの順jこ溶かし、112に仕上げて用いた
。この定着液のpHは酢酸で4.8に調整した。Developer prescription Developer solution 1
Developer 2 Ethylenediaminetetraacetic acid sodium salt
1g 1g sodium sulfite
60g 60g trisodium phosphate (1
dihydrate) 75g Boric acid -40g Hydroquinone 22.5
g 35g sodium hydroxide
8g 8g Sodium Bromide
3g 3g5-Methylbenzotriazole 0.25g 0.2g
1-phenyl-5-mercaptotetrazole 0.
08g 0.08g1-phenyl-4-methyl-4-
Hydroxymethyl -0,2g3-Vyrazolidonemethol 0.25g
Phenethylpicolinium bromide -2,5
g Add water 112
Adjust pH with sodium 12 hydroxide
pH-10,8pH=1O,8 Fixer formulation (composition A) Ammonium thiosulfate C72,5w/v% water soluble)
240m12 Sodium sulfite
17g Sodium acetate trihydrate
6.5μm 1m
6g Sodium citrate dihydrate
2g (composition) Pure water (ion exchange water) 17mΩ Sulfuric acid (50% W/V aqueous solution)
4.7g aluminum sulfate
26.5 g (an aqueous solution with an AI220s equivalent content of 8.1 w/v %) When using a fixer, the above composition A1 was dissolved in 500 mff of water and finished to 112 before use. The pH of this fixer was adjusted to 4.8 with acetic acid.
(現像処理条件)
(工 程) (温 度) (時 間)現 像
406CI5 秒水 着 35
°C15抄
本 洗 300 10 秒乾
燥 50 ℃ 10 秒間、処方
(1)におけるハロゲン化銀乳剤層に添加した本発明に
係るヒドラジン誘導体の比較化合物としては、以下の(
a)及び(b)の化合物を添加した。(Development processing conditions) (Process) (Temperature) (Time) Development
406CI5 second swimsuit 35
Extract washed at 15°C and dried for 10 seconds at 300°C.
Drying at 50° C. for 10 seconds. Comparison compounds of the hydrazine derivative according to the present invention added to the silver halide emulsion layer in formulation (1) include the following (
Compounds a) and (b) were added.
化合物(a)
(a)
表−1から明らかなように本発明に係る試料は、比較に
対して、網点品質と黒ピンが良いことがわかる。Compound (a) (a) As is clear from Table 1, the samples according to the present invention have better halftone dot quality and black pins than the comparison.
本発明により、pH11未満の低pi(の現像液で処理
しても、硬調でカブリが少なく網点性能の良好なハロゲ
ン化銀写真感光材料を提供することができた。According to the present invention, it was possible to provide a silver halide photographic light-sensitive material that has high contrast, less fog, and good halftone dot performance even when processed with a low-pi developer having a pH of less than 11.
Claims (1)
化銀写真感光材料において、下記一般式〔A〕で表され
るヒドラジン化合物を少なくとも1種含有し、かつアミ
ン化合物、ヒドラジン化合物、四級オニウム塩化合物か
ら選ばれる少なくとも1種の造核促進化合物を含有する
ことを特徴とするハロゲン化銀写真感光材料。 一般式〔A〕 ▲数式、化学式、表等があります▼ 〔式中、Arはアリール基を表し、Xは−NR_1R_
2又は−OR_3を表し、R_1及びR_2は各々、水
素原子、アルキル基、アルケニル基、アルキニル基、ア
リール基、複素環基、ヒドロキシル基、アルコキシ基、
アルケニルオキシ基、アルキニルオキシ基、アリールオ
キシ基又は複素環オキシ基を表し、R_1とR_2は窒
素原子と共に環を形成してもよい。 R_3は水素原子、アルキル基、アルケニル基、アルキ
ニル基、アリール基又は複素環基を表す。 Rは水素原子又はアルキル基を表し、nは0又は1を表
し、mは1〜3の整数を表す。 ただし、一般式〔A〕で表される化合物中、少なくとも
一つのRはハロゲン化銀への吸着促進基を有するか、又
は、分子中のRの合計として耐拡散性を付与するものと
する。 一般式〔A〕で表される化合物には、式中の−NHNH
−の少なくともいずれかのHが置換基で置換されたもの
を含む。〕[Scope of Claims] A silver halide photographic material having at least one silver halide emulsion layer, containing at least one hydrazine compound represented by the following general formula [A], and containing an amine compound, a hydrazine compound A silver halide photographic light-sensitive material comprising at least one nucleation-promoting compound selected from , quaternary onium salt compounds. General formula [A] ▲There are mathematical formulas, chemical formulas, tables, etc.▼ [In the formula, Ar represents an aryl group, and X is -NR_1R_
2 or -OR_3, R_1 and R_2 each represent a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heterocyclic group, a hydroxyl group, an alkoxy group,
It represents an alkenyloxy group, an alkynyloxy group, an aryloxy group, or a heterocyclic oxy group, and R_1 and R_2 may form a ring together with a nitrogen atom. R_3 represents a hydrogen atom, an alkyl group, an alkenyl group, an alkynyl group, an aryl group, or a heterocyclic group. R represents a hydrogen atom or an alkyl group, n represents 0 or 1, and m represents an integer of 1 to 3. However, in the compound represented by the general formula [A], at least one R has a group that promotes adsorption to silver halide, or the sum of R in the molecule imparts diffusion resistance. The compound represented by the general formula [A] includes -NHNH in the formula
- includes those in which at least one of H is substituted with a substituent. ]
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20080990A JP2896698B2 (en) | 1990-07-26 | 1990-07-26 | Silver halide photographic material |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP20080990A JP2896698B2 (en) | 1990-07-26 | 1990-07-26 | Silver halide photographic material |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH0484134A true JPH0484134A (en) | 1992-03-17 |
JP2896698B2 JP2896698B2 (en) | 1999-05-31 |
Family
ID=16430559
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP20080990A Expired - Lifetime JP2896698B2 (en) | 1990-07-26 | 1990-07-26 | Silver halide photographic material |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2896698B2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000044754A1 (en) * | 1999-01-29 | 2000-08-03 | Sumitomo Chemical Company, Limited | Fat accumulation inhibitory agents |
-
1990
- 1990-07-26 JP JP20080990A patent/JP2896698B2/en not_active Expired - Lifetime
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000044754A1 (en) * | 1999-01-29 | 2000-08-03 | Sumitomo Chemical Company, Limited | Fat accumulation inhibitory agents |
Also Published As
Publication number | Publication date |
---|---|
JP2896698B2 (en) | 1999-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2965719B2 (en) | Silver halide photographic material | |
JP3041736B2 (en) | Silver halide photographic material | |
JPH0484134A (en) | Silver halide photographic sensitive material | |
JPH0476530A (en) | Silver halide photographic sensitive material | |
JPH03259240A (en) | Silver halide photographic sensitive material | |
JP2835647B2 (en) | Silver halide photographic material | |
JPH0467140A (en) | Silver halide photographic sensitive material | |
JP2681654B2 (en) | Silver halide photographic material | |
JPH04114145A (en) | Silver halide photographic sensitive material | |
JPH0456949A (en) | Silver halide photographic sensitive material | |
JPH05134337A (en) | Silver halide photographic sensitive material | |
JP2873854B2 (en) | Processing method of silver halide photographic material | |
JP3208688B2 (en) | Silver halide photographic materials | |
JPH03282447A (en) | Silver halide photographic sensitive material | |
JP2939675B2 (en) | Silver halide photographic material | |
JPH0561139A (en) | Silver halide photographic sensitive material | |
JPH0477732A (en) | Silver halide photographic sensitive material | |
JPH0462544A (en) | Method for forming high-contrast negative image | |
JPH049039A (en) | Silver halide photographic sensitive material | |
JPH06250348A (en) | Developing method for silver halide photographic sensitive material | |
JPH05134339A (en) | Silver halide photographic sensitive material | |
JPH0713284A (en) | Silver halide photographic sensitive material | |
JPH02285342A (en) | Silver halide photographic sensitive material capable of forming image high in contrast | |
JPH04194923A (en) | Image forming method | |
JPH02285343A (en) | Silver halide photographic sensitive material capable of forming image high in contrast |